Skip to main content
eLife logoLink to eLife
. 2023 Feb 7;12:e74899. doi: 10.7554/eLife.74899

A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex

Vera Valakh 1, Derek Wise 1, Xiaoyue Aelita Zhu 1, Mingqi Sha 1, Jaidyn Fok 1, Stephen D Van Hooser 1, Robin Schectman 1, Isabel Cepeda 1, Ryan Kirk 1, Sean M O'Toole 1, Sacha B Nelson 1,
Editors: Yukiko Goda2, Gary L Westbrook3
PMCID: PMC10010687  PMID: 36749029

Abstract

Healthy neuronal networks rely on homeostatic plasticity to maintain stable firing rates despite changing synaptic drive. These mechanisms, however, can themselves be destabilizing if activated inappropriately or excessively. For example, prolonged activity deprivation can lead to rebound hyperactivity and seizures. While many forms of homeostasis have been described, whether and how the magnitude of homeostatic plasticity is constrained remains unknown. Here, we uncover negative regulation of cortical network homeostasis by the PARbZIP family of transcription factors. In cortical slice cultures made from knockout mice lacking all three of these factors, the network response to prolonged activity withdrawal measured with calcium imaging is much stronger, while baseline activity is unchanged. Whole-cell recordings reveal an exaggerated increase in the frequency of miniature excitatory synaptic currents reflecting enhanced upregulation of recurrent excitatory synaptic transmission. Genetic analyses reveal that two of the factors, Hlf and Tef, are critical for constraining plasticity and for preventing life-threatening seizures. These data indicate that transcriptional activation is not only required for many forms of homeostatic plasticity but is also involved in restraint of the response to activity deprivation.

Research organism: Mouse

eLife digest

The human brain is made up of billions of nerve cells called neurons which receive and send signals to one another. To avoid being over- or under-stimulated, neurons can adjust the strength of the inputs they receive by altering how connected they are to other nerve cells.

This process, known as homeostatic plasticity, is thought to be necessary for normal brain activity as it helps keep the outgoing signals of neurons relatively constant. However, homeostatic plasticity can lead to seizures if it becomes too strong and overcompensates for weak input signals. Regulating this process is therefore central to brain health, but scientists do not understand if or how it is controlled.

To address this, Valakh et al. analyzed the genes activated in neurons lacking incoming signals to find proteins that regulate homeostatic plasticity. This revealed a class of molecules called transcription factors (which switch genes on or off) that constrain the process. In brain samples from mice without these regulatory proteins, neurons received twice as much input, leading to an increase in brain activity resembling that observed during seizures. Valakh et al. confirmed this finding using live mice, which developed seizures in the absence of these transcription factors.

These findings suggest that this type of regulation to keep homeostatic plasticity from becoming too strong may be important. This could be especially vital as the brain develops, when the strength of connections between neurons changes rapidly. The discovery of the transcription factors involved provides a potential target for activating or restraining homeostatic plasticity. This control could help researchers better understand how the process stabilizes brain signaling.

Introduction

Neuronal networks are equipped with a set of homeostatic plasticity mechanisms that enable them to rebalance activity following perturbations during development, learning, or disease. Homeostatic plasticity can alter the intrinsic excitability of individual neurons, as well as the strength and number of both excitatory and inhibitory synapses (Davis, 2006; Turrigiano and Nelson, 2004). Synaptic changes can occur post- (Turrigiano et al., 1998) or presynaptically (Delvendahl and Müller, 2019) and may scale quantal amplitudes and alter the frequency of quantal events. These changes are homeostatic because they occur in the direction needed to rebalance the network after activity perturbation. Especially during development, homeostatic mechanisms are strong and can be maladaptive if they overshoot or are activated inappropriately (Nelson and Valakh, 2015).

Despite recognition of the significance of homeostatic plasticity, whether and how its strength is normally constrained has remained unknown. Downregulation of the strength of homeostatic plasticity could potentially provide protection against inappropriate or excessive activation of these mechanisms. However, such negative regulators of homeostatic plasticity have not been previously described.

Here, we investigate the role of the proline and acidic amino acid-rich basic leucine zipper (PAR bZIP) family of transcription factors (TFs) in homeostatic plasticity. The family consists of hepatic leukemia factor (HLF), thyrotroph embryonic factor (TEF), and albumin D-site-binding protein (DBP) which are thought to act as transcriptional activators, as well as E4 Promoter-Binding Protein 4 (E4BP4, currently known as Nfil3) that acts as a transcriptional repressor (Mitsui et al., 2001). All four family members share the same DNA binding motif. DBP is a circadian gene controlled by CLOCK and oscillates with circadian rhythm (Ripperger et al., 2000). Other family members are also controlled by CLOCK (Li et al., 2017). However, while these TFs typically have oscillatory behavior in peripheral tissue, they do not oscillate in the brain outside of the SCN (Gachon et al., 2004). Loss of HLF, TEF, and DBP has been associated with epilepsy (Gachon et al., 2004; Hawkins and Kearney, 2016; Rambousek et al., 2020) suggesting they are important in regulating network activity.

In order to investigate the role that gene transcription plays in regulating the neuronal response to activity deprivation, we profiled changes in gene expression engaged during homeostatic plasticity and found that prolonged activity deprivation activates a robust transcriptional program involving the PARbZIP TF family members HLF and TEF. Both act to restrain the expression of homeostatic plasticity. While they have limited effects on network function at baseline, they strongly suppress the upregulation of homeostatic changes, mainly by regulating recurrent excitatory synaptic connections, although inhibition is also affected. Taken together, these results indicate that homeostatic plasticity is itself subject to activity-dependent regulation and is transcriptionally restrained by the PARbZIP TFs HLF and TEF.

Results

PARbZIP transcripts increase during activity deprivation

Certain forms of homeostatic plasticity require transcription (Goold and Nicoll, 2010; Ibata et al., 2008) and activity perturbation results in changes in gene expression (Schaukowitch et al., 2017). We hypothesized that among the differentially expressed genes, some induce or regulate homeostatic changes. To identify novel genes involved in the homeostatic response to activity deprivation, we measured gene expression in excitatory and inhibitory neurons in organotypic slice cultures following a global decrease in activity. We cut coronal slices including neocortex at P7 and cultured them for 5 days. During this culture period, the neurons reform connections, and spontaneous bouts of activity, termed upstates, emerge (Johnson and Buonomano, 2007; Koch et al., 2010). To broadly block activity, we applied the voltage-gated sodium channel blocker tetrodotoxin, TTX (0.5 μM), for 5 days during an early developmental period (equivalent postnatal days, EP, 12–17). This manipulation induces a robust homeostatic program and profoundly changes network dynamics (Koch et al., 2010; Schaukowitch et al., 2017). To characterize the changes in gene expression, we sorted deep layer (L5 and L6) pyramidal and PV+ interneurons and performed RNA sequencing to look for transcripts that change following prolonged silencing. Inactivity activates a robust transcriptional program of both positively and negatively affected genes (Figure 1A) consistent with data from dissociated hippocampal cultures (Schaukowitch et al., 2017). To identify transcriptional regulators of homeostatic plasticity, we looked for TFs upregulated in the TTX condition. TFs can be classified into families, and in some cases subfamilies, which share a DNA binding domain, and so are expected to bind the same target DNA sequences in the genome and therefore to regulate the same or similar target transcripts. We asked which families or subfamilies were most overrepresented among the TFs differentially expressed during activity blockade. The most overrepresented subfamily or family was the PARbZIP subfamily of TFs, a subtype of the CEBP-related family in the class of Basic leucine zipper factors (classification data from tfclass.bioinf.med.uni-goettingen.de; Wingender et al., 2015). This subfamily includes three transcriptional activators Hlf, Tef, and Dbp, and a transcriptional repressor, Nfil3. Expression levels of Dbp are much lower than those of Hlf and Tef (<3 TPM in excitatory and PV+ inhibitory neurons), suggesting that this family member may play a more limited role in the neocortex. Both Hlf and Tef are robustly upregulated after 5 days of activity deprivation in both excitatory (fold change [FC] TTX/control; FC = 2.6, 2.5; adjusted p value; padj = 1.3e−8, 3.8e−4,) and inhibitory neurons (FC = 7.0, 2.1; padj = 4.6e−39, 2.0e−3), while Nfil3 and Dbp were not (FC = 0.51, 1.9; padj = 0.49, 0.80, excitatory; FC = 1.2, 1.4; padj = 0.84, 0.79 inhibitory).

Figure 1. RNA-sequencing identifies transcripts affected by activity deprivation including the PARbZIP family of transcription factors.

Figure 1.

(A) Volcano plots of bulk RNA-seq from sorted fluorescently labeled pyramidal cells (left) and PV+ interneurons (right). Dashed lines indicate a fold change of 2 and adjusted p value of 0.05. Differential expression analysis revealed that TTX resulted in upregulation (513 in pyramidal, 1415 in PV+ interneurons) as well as downregulation (605 in pyramidal, 1127 in PV+ interneurons) of genes, among which Hlf and Tef were identified as upregulated with activity block in both excitatory and inhibitory neurons. Statistical analysis (Wald test followed by Benjamini-Hochberg correction) reveals that Hlf and Tef are significantly upregulated in both pyramidal cells and PV+ interneurons, while Dbp and Nfil3 are not significantly altered in either cell type. (B) Bar graphs displaying transcript per million (TPM) values of Hlf (left panel) and Tef (right panel) in pyramidal cells (left) and interneurons (right) in control and 5-day TTX treated slices. Bars are mean values +/- SEM, open symbols are individual experiments. (C). Quantitative real-time PCR analysis of Hlf and Tef expression in whole cortex lysates following a time course of activity deprivation (n = 3–4 slices per time point; error bars are SEM). Two-way ANOVA reveals significant differences between Hlf/Tef and RPL10 (p<0.05).

Figure 1—source data 1. qPCR Data.

To validate this finding and to further dissect the time course of PARbZIP TFs expression, we isolated the whole cortex from slice cultures and measured Hlf and Tef transcript levels at various time points during activity deprivation using real-time quantitative PCR. We find that upregulation occurs soon after activity withdrawal, since by 4 hr of TTX application the level of both TFs is already substantially elevated (Figure 1C), consistent with previous findings in dissociated hippocampal cultures (Schaukowitch et al., 2017). We also find that Hlf and Tef continue to increase with time, suggesting that their upregulation correlates with how long the network has been silenced.

PARbZIP TFs restrain network homeostatic plasticity

Since Hlf and Tef are progressively upregulated during prolonged TTX treatment, which can lead to subsequent epilepsy (Galvan et al., 2000; Scharfman, 2002), we entertained the hypothesis that they may contribute to the homeostatic increase in network excitability following activity deprivation. On the other hand, loss of function of members of the PARbZIP family of TFs are also associated with epileptic phenotypes (Hawkins and Kearney, 2016; Hawkins and Kearney, 2012; Rambousek et al., 2020). Specifically, triple knockout (TKO) Hlf−/−/Dbp−/−/Tef−/ mice have epilepsy (Gachon et al., 2004). One possibility that reconciles this apparent conflict is that instead of driving homeostatic plasticity, Hlf and Tef are upregulated in the TTX condition to restrain homeostatic responses. To test this hypothesis, we investigated the role that these TFs play in homeostatic plasticity. We induced homeostatic upregulation of network function by 2-day TTX application in organotypic slice cultures and measured network activity after TTX removal.

As a read-out of network activity, we measured changes in intracellular calcium using virally delivered GCaMP6f in primary somatosensory cortex (Figure 2A). In untreated slices at baseline, the neurons display population activity organized into complex, infrequent upstates which are similar to those observed in vivo (Figure 2B, Sanchez-Vives and McCormick, 2000). To quantify network activity, we measured the frequency of Ca2+ peaks in each recording and the synchrony of calcium transients across cells (see Methods for detailed description of quantitative analysis). After 2 days of TTX treatment, the frequency of the upstates increases. While 2 days of TTX incubation increases the peak frequency 3.6-fold in wild-type (WT) slices (from 0.06 ± 0.01 to 0.22 ± 0.04 Hz), the same silencing duration produces a nearly sixfold increase in the TKO slices (from 0.09 ± 0.02 to 0.5 ± 0.05 Hz; Figure 2, Figure 2—figure supplement 1A). A two-way ANOVA revealed significant effects of treatment (TTX vs. Control; p<0.0001) and genotype (p<0.0001) and a significant interaction between the two (p<0.0001). Post hoc t tests (with Tukey correction for multiple comparisons) revealed that TTX increases in activity were highly significant in both WT (p=0.0007) and TKO (p<0.0001) slices and that TTX produced a significantly stronger increase in the TKO (p<0.0001), while the baseline activity of cells from slices derived from the TKO and WT do not differ significantly (p=0.92). Consistent with this, normalizing the TTX response to the control response revealed a larger relative increase in TKO than WT cultures (Figure 2—figure supplement 1A). The TTX condition also increased synchrony (from 0.76 ± 0.03 to 0.95 ± 0.01) in WT, and in the TKO (from 0.74 ± 0.03 to 0.94 ± 0.05; Figure 2—figure supplement 1B). While the TTX effects were highly significant (two-way ANOVA; p<0.0001), there was no significant effect of genotype (p=0.43) and no interaction between treatment and genotype (p=0.65), presumably reflecting the fact that synchrony is already saturated by TTX treatment in the WT and cannot further increase in the TKO, but also indicating that baseline synchrony is not altered in the TKO. A power test revealed that with the effect size and variances observed, 95 slice cultures in each group would be needed to detect a significant difference between WT and TKO peak frequency, while for the synchrony measure, the required N would be 1609. These data suggest that the PARbZIP family of TFs normally functions to restrain homeostatic plasticity, and in their absence, the homeostatic response is exaggerated. Moreover, even though the mutation is associated with epilepsy, it does not make cortical neuronal circuits more excitable at baseline.

Figure 2. Calcium imaging reveals exaggerated response to activity deprivation in Hlf−/−/Dbp−/−/Tef−/ triple knockout (TKO) slices.

(A). A confocal image of GCaMP6f fluorescence during an upstate in wild-type (WT) control slice (top panel) and a standard deviation projection of the same field of view of calcium signal during 1 min of recording (bottom panel). Scale bar = 50 µm. ROIs were manually selected around active cells identified by high standard deviation values. (B, C) GCaMP6f fluorescence heat map of selected ROIs (each row is one cell) during 1 min of recording (top panels) also shown as overlapping traces (gray, bottom panels) and an average fluorescence trace (black, bottom panels) in WT (B) and TKO slices (C) from control (left) and TTX-treated conditions (right). Traces show absolute dF/F, heatmap scale is normalized for each cell so that the full intensity range corresponds to the range of dF/F. (D) Quantification of peak frequency in GCaMP6f fluorescence traces. N = 16 slices for WT Control, N = 13 WT TTX, N = 8 TKO Control, and N = 11 TKO TTX. Error bars indicate SEM. TTX treatment significantly increases peak frequency in WT slices with significant (p<0.0001) interaction between treatment and genotype. The increase is more dramatic in the TKO slices. Two-way ANOVA with Tukey’s correction for multiple comparisons to test statistical significance between conditions *p≤0.0001.

Figure 2—source data 1. Calcium imaging analysis summary, 2D TTX; WT, TKO.

Figure 2.

Figure 2—figure supplement 1. Ca2+ activity in mutant slices is similarly exaggerated after 2 and 5 days of activity withdrawal.

Figure 2—figure supplement 1.

(A) Quantification of peak frequency (from Figure 1D) normalized to control in WT and TKO slices after 2 days of activity deprivation. (B) Quantification of peak synchrony values in each of the conditions in (A). Open symbols are individual slice cultures, filled bars are mean ± SEM. Synchrony values in WT condition are close to 1 and do not show further increase in the TKO slides. (C) Quantification of peak frequency after 5 days of activity deprivation and traces from representative slices (D) of the genotypes in (C). Increasing TTX incubation time to 5 days of TTX does not change the TKO phenotype. Peak frequency increased in WT (from 0.06 ± 0.01 to 0.24 ± 0.02) and this response is exaggerated in the TKO (from 0.05 ± 0.005 to 0.47 ± 0.04; a 2.5-fold greater increase than in WT). As at 2 days, two-way ANOVA revealed significant main effects for TTX (p < 0.0001) and genotype (p < 0.0001) and a significant interaction between treatment and genotype (p < 0.0001) and post hoc test (Tukey) revealed a significant difference between WT TTX and TKO TTX (p < 0.0001), but no difference between WT and TKO control activity (p = 0.97). Also, as at 2 days, synchrony increased dramatically in the presence of TTX in both genotypes (to 0.96 and 0.93) but this was not significantly different and there was also no significant difference in the values at baseline in the two genotypes (0.54 and 0.58). N = 9 for WT control, N = 9 for WT TTX, N = 13 for TKO control, and N = 9 for TKO TTX. TKO, triple knockout; WT, wild-type.
Figure 2—figure supplement 1—source data 1. Calcium imaging analysis summary, 5D TTX; WT, TKO.
Figure 2—figure supplement 2. Ca2+ activity recovers to baseline levels following washout of TTX in both wild-type and mutant slices.

Figure 2—figure supplement 2.

(A) Representative GCaMP6f fluorescence intensity over 1 min of recording in WT (left panels) and TKO slices (right panels) during control (top row), immediately after TTX washout (middle row) and after 2 days of recovery following TTX washout (bottom row). (B) Quantification of peak frequency in each of the conditions in (A). Open symbols are individual slice cultures, filled symbols are mean ± SEM. Two-way ANOVA revealed significant main effect for drug treatment (p < 0.0001) and genotype (p = 0.0009) and a significant interaction between treatment and genotype (p = 0.017). Although TTX incubation has a much stronger effect on spontaneous Ca2+ activity immediately after washout in mutant slices (p < 0.0001, post hoc Tukey test), the activity returns to baseline in both genotypes (p = 0.99, post hoc Tukey test). N = 5 for WT age-matched control, N = 3 for TKO age-matched control, N = 11 for WT TTX, N = 11 for TKO TTX, N = 5 for WT recovery, and N = 4 for TTX recovery. TKO, triple knockout; WT, wild-type.
Figure 2—figure supplement 2—source data 1. Calcium imaging analysis summary, recovery.

Recovery from activity deprivation is unperturbed in the mutant slices

Homeostatic plasticity is thought to provide flexibility to the network and thus most forms are reversed after reintroduction of activity (Desai et al., 2002; Hobbiss et al., 2018; Koch et al., 2010; Wallace and Bear, 2004). Reversal involves a homeostatic reduction of abnormally elevated activity. Even when this involves symmetric opposing changes in the same biophysical parameters altered in the response to activity deprivation (such as with downscaling and upscaling of excitatory quantal amplitudes), the mechanisms involved typically differ (Stellwagen and Malenka, 2006; Sun and Turrigiano, 2011; Tan et al., 2015; Wang et al., 2017). In addition, changes in activity following rebound from deprivation could reflect either a change in the vigor of the circuit’s attempt to restore activity (i.e., enhanced homeostatic plasticity) or a persistent change in the setpoint to which activity is returned (Styr et al., 2019), or both. To test whether the transcriptional restraint of homeostasis is required for bidirectional flexibility and to assess whether the setpoint had changed, we asked whether the network is able to return back to baseline activity levels when the activity blockade is removed. We measured network activity immediately after the end of silencing with TTX as well as following two days of recovery in TTX-free media. In WT slices, activity deprivation causes hyperactivity, evident from a twofold rise in the peak frequency of the calcium activity. However, this exuberant activity is restored back to baseline levels within 2 days following restoration of action potential firing. In the TKO slices, even though the initial response to TTX is exaggerated, the network is also able to return to baseline levels following 2 days of recovery, to levels indistinguishable from WT (Figure 2—figure supplement 2). These data suggest that the recovery from a high activity state is not diminished in the TKO and suggest that the mutation in fact produces exaggerated homeostatic plasticity rather than a change in activity setpoint.

Frequency, but not amplitude, of mEPSCs is disproportionately upregulated by deprivation in TKO slices

Network activity is unaltered in the mutant at baseline but the response to activity deprivation is exaggerated. To learn more about the mechanism by which Hlf and Tef restrain homeostatic plasticity, we probed the effects of TTX on excitatory synaptic transmission. Because of the high levels of spontaneous network activity, it was not feasible to study unitary action potential evoked transmission. Instead, to broadly assay the properties of excitatory synapses, we measured pharmacologically isolated AMPA-receptor driven miniature EPSCs in control and TTX-treated slices. We observed a robust upregulation of mEPSC amplitude following 2 days of activity deprivation, consistent with our understanding of homeostatic synaptic scaling (Turrigiano et al., 1998). We also observed a large increase in mEPSC frequency, which has also been described in this preparation (Koch et al., 2010) and in multiple other preparations (Wierenga et al., 2006). In the TKO mice, the synaptic scaling is unaffected (Figure 3A and C; amplitude increased from 13.4 ± 1.1 to 18.5 ± 1.2 pA in WT and from 13.2 ± 1.4 to 19.7 ± 1.1 pA in TKO) but the increase in mEPSC frequency in response to activity deprivation is more dramatic (Figure 3B and D; 4.0 ± 0.8 to 6.2 ± 0.7 Hz in WT vs. 3.5 ± 0.5–9.3 ± 1.0 Hz in the KO). Notably, both the frequency and amplitude of mEPSCs are the same between WT and mutant slices at baseline which parallels our observations of network activity (Figure 2). These results suggest that the members of the PARbZIP family of TFs function to restrain upregulation of mEPSC frequency in response to activity deprivation and this increase is correlated with changes in activity levels across the network.

Figure 3. Frequency but not amplitude of excitatory synaptic currents is disproportionally upregulated in TTX-treated TKO slices.

Figure 3.

(A) Representative traces of mEPSC recordings from WT control (black), WT TTX-treated (red), TKO control (gray), and TKO TTX-treated (blue) slices. Right panel, average mEPSC waveforms for the same conditions. Both the frequency and the amplitude is increased in TTX-treated slices; however, the increase in frequency is more dramatic in TKO slices. (B) Quantification of mEPSC frequency for each condition. Colored bars with error bars are mean ± SEM, open circles are individual cells; N = 24 for WT control, N = 29 for WT TTX, N = 18 for TKO control, and N = 24 for TKO TTX. Two-way ANOVA revealed significant main effect of TTX treatment (p < 0.0001), genotype alone (p=0.030) and interaction between treatment and genotype (p = 0.041). Post hoc Tukey test revealed enhanced effect of TTX on mEPSC frequency in TKO cells compared to WT (p = 0.009, **). (C) Cumulative probability histogram for mEPSC inter-event intervals in each condition. (D) Cumulative probability histogram for mEPSC amplitudes in each condition. (E) mEPSC amplitudes for each condition. Two-way ANOVA revealed significant main effect for drug treatment (p < 0.0001) but not genotype (p = 0.74) or interaction between treatment and genotype (p = 0.55). TTX treatment enhanced mEPSC amplitude in both WT (p = 0.012, Tukey post hoc test, *) and TKO (p = 0.0035, Tukey post hoc test, **) to the same extent (p = 0.89, WT TTX compared to TKO TTX, Tukey post hoc test, N.S.). TKO, triple knockout; WT, wild-type.

Figure 3—source data 1. mEPSC amplitude and frequency.

Neither the frequency nor amplitude of mIPSCs in pyramidal neurons in the TTX condition is affected in the TKO

Since L5 pyramidal neurons also receive inhibitory input, which is also subject to homeostatic plasticity (Kilman et al., 2002; Kim and Alger, 2010), we wanted to determine whether the response of mIPSCs to activity deprivation is also exaggerated in the mutant mice. In WT cultures, measurement of inhibitory input onto L5 pyramidal neurons revealed that both the amplitude and frequency of mIPSCs drop in response to activity deprivation (Figure 4). When we measured mIPSCs in pyramidal neurons from TKO slices, we saw a similar decrease in frequency following 48 hr TTX treatment, although the amplitude of the change was smaller than in the WT (Figure 4B and C). In contrast, the mIPSC amplitude change is abolished: mIPSC amplitude is decreased at baseline compared to WT but did not show a further decrease after TTX treatment (Figure 4D and E). However, the decreased amplitude in the untreated condition does not correlate with the unchanged baseline network activity levels (Figure 2), suggesting that the decrease of mIPSCs amplitude at baseline may be insufficient on its own to cause network hyperexcitability. Thus, both the amplitude and frequency of mIPSCs received by pyramidal neurons after activity deprivation are indistinguishable from the WT in the TKO slices, suggesting that homeostatic plasticity of mIPSCs is not directly driving the changes in the network activity following TTX treatment. We cannot rule out the possibility that although baseline activity is normal, the baseline reduction in mIPSC amplitude contributes to subsequent network plasticity indirectly, by contributing to induction of the changes in EPSCs observed, or by inducing some form of compensation other than the physiological parameters measured.

Figure 4. Inhibitory synaptic currents are not affected by the Hlf−/−/Dbp−/−/Tef−/ mutation in the TTX condition.

Figure 4.

(A) Representative traces of mIPSC recordings from WT control (black), WT TTX-treated (red), TKO control (gray), and TKO TTX-treated (blue) slices. Right panel, average mIPSC waveforms for the same conditions. TTX treatment results in a diminished effect on mIPSC frequency in TKO and does not further decrease the amplitude of mIPSCs in TKO slices. (B) Quantification of mIPSC frequency. Colored bars with error bars are mean ± SEM, open circles are individual cells. Two-way ANOVA revealed a significant main effect of TTX treatment (p < 0.0001) but not genotype (p = 0.54). There was no significant interaction between treatment and genotype (p = 0.40), N = 28 for WT control, N = 37 for WT TTX, N = 23 for TKO control, and N = 20 for TKO TTX. TTX treatment decreased mIPSC frequency in WT (p = 0.0007, post hoc Tukey test) but not in TKO cells (p = 0.14, post hoc Tukey test). mIPSC frequency in TTX-treated cells is not different in TKO slices compared to WT (p = 0.72). The normalized change in frequency (TTX normalized to Control) was 0.55 in WT and 0.70 in TKO. We performed a power analysis that revealed that for the observed effect size and variance a sample of 68 neurons per condition would be required for significance. In (B), (C), and (E), cumulative probability histogram for mIPSC inter-event intervals in each condition. (D) Cumulative probability histogram for mIPSC amplitudes in each condition. (E) Quantification of mIPSC amplitudes for the same conditions as in (B). Two-way ANOVA revealed significant main effect of TTX (p = 0.002), and genotype (p = 0.0067), and a significant interaction between treatment and genotype (p = 0.005). TTX treatment decreased mIPSC amplitude in WT (p < 0.0001, Tukey post hoc test, ***), but not in TKO cells (p = 0.997, Tukey post hoc test, N.S.) presumably due to significantly lower baseline mIPSC amplitude in TKO slices compared to WT (p = 0008, post hoc Tukey test, ***). TKO, triple knockout; WT, wild-type.

Figure 4—source data 1. mIPSC amplitude and frequency.

Intrinsic excitability of pyramidal neurons is unaffected in TKO slices

Changes in neuronal excitability have also been described as part of the homeostatic response to activity deprivation (Desai et al., 1999; Karmarkar and Buonomano, 2006; Lambo and Turrigiano, 2013; Moore et al., 2018; Yoshimura and Rasband, 2014). We wanted to test whether changes in intrinsic excitability could be contributing to the exaggerated homeostatic response in the TKO slices similarly to mEPSCs. WT L5 pyramidal neurons become more excitable following prolonged activity deprivation (Figure 5; Desai et al., 1999). To account for difference in the proportion of adapting and non-adapting neurons (Hattox and Nelson, 2007) causing apparent changes in intrinsic excitability due to uneven sampling of the two groups, we measured the adaptation ratio of each cell and analyzed an equal number of adapting and non-adapting cells in each genotype. Changes in excitability due to activity deprivation are accompanied by a shift in the average adaptation ratio of the cells in both WT and TKO slices (control WT: 3.8 ± 0.16, TTX WT: 0.72 ± 0.22, TKO control: 0.46 ± 0.25, TKO TTX: 0.71 ± 0.33; two-way ANOVA significant difference between control and TTX and no significant difference between WT and TKO). Excitatory neurons in L5 in the slices prepared from TKO animals are equally excitable at baseline and also show upregulation of intrinsic excitability to the same extent (Figure 5). These results suggest that changes in intrinsic excitability are not driving the exaggerated network response to activity deprivation and this form of homeostatic plasticity is not under the control of the Par bZIP TF family.

Figure 5. The effects of TTX on intrinsic excitability are not altered in TKO pyramidal neurons.

Figure 5.

(A) Comparisons of frequency-current relationships for layer five pyramidal neurons in control (black, closed circles) and TTX-treated (red, closed circles) WT slices, and in control (gray, open circles), and TTX-treated (blue, open circles) TKO slices, N = 27 cells for WT TTX, N = 16 for WT control, N = 8 for TKO control, and N = 17 for TKO TTX; error bars are SEM. Two-day TTX treatment increases intrinsic excitability in both WT and TKO slice cultures to a similar extent. A three-way mixed ANOVA with between subjects factors of treatment and genotype, and a within subjects factor of current level, revealed significant main effects for TTX treatment (F(1,60) = 18.1, p = 7.3e−05) and current level (F(11,660) = 2.3e−190) but not for genotype (F(1,60) = 0.06, p = 0.94). There was a significant interaction between treatment and current level (p = 0.06) but not for interactions of genotype with current level (p = 0.93) or with both current level and treatment (p = 0.99). (B) Example traces of a train of action potentials from a pyramidal neuron in response to a 175 pA 0.5 s depolarizing current injection in control (left), TTX-treated (right), WT (top), or TKO (bottom) slices. TKO, triple knockout; WT, wild-type.

Figure 5—source data 1. Frequency-Current curves.

PARbZIP family members play unequal roles in restraining homeostatic plasticity

Expression of both Hlf and Tef increase in excitatory neurons following activity deprivation. Because all three Par bZIP family members form homo- and heterodimers and bind to the same PAR-response element (Gachon, 2007), they may be able to compensate for one another. To test whether Hlf, Tef, and Dbp work together to regulate homeostatic plasticity or if they have unequal contributions to restraining network response to activity deprivation, we measured the homeostatic response while varying gene copy number of each TF. In addition to the WT and TKO data described in Figure 2 and Figure 2—figure supplement 1, we measured calcium transients in slice cultures treated with or without TTX from 97 additional animals with various combinations of 0, 1, or 2 alleles of Hlf, Tef, and Dbp (full details of each experiment given in associated data file). Rather than attempt to statistically test individual differences between each of 27 potential genotypes (Null, Het, wild-type for the three genes considered jointly), we fit a series of multivariate linear models to test the ability of genotype to predict calcium peak frequency. The same six models, described in Table 1, were fit separately to data from control and TTX-treated slices. The models, shown in Table 1, differ in how they depend on the number of alleles of each of the three genes. Model 1 depends on all three genes, models 2–4 depend only on one of the three genes (each in turn), and models 5 and 6 depend only on Hlf and Tef, either independently, or summed together. The ability of each model to account for the data was estimated from the adjusted R2 which reflects the fraction of the variance in the data predicted by the model variables. Several key points were evident from this analysis:

Table 1. Multivariate linear models of the dependence of calcium peak frequency (PF) on genotype.

Listed linear models were fit to peak frequencies of calcium transients measured from 87 control and 98 TTX-treated slices each from separate animals that differed in their genotype (null, heterozygote or wild-type) for each of the Hlf, Tef, and Dbp genes. The data (see attached file) includes the 88 experiments shown in Figure 2 and Figure 2—figure supplement 1 (WT and TKO) as well as 97 additional experiments (intermediate genotypes). Regressions were performed using the lm function in R where the variables Hlf, Tef, and Dbp represent the numbers of alleles of each gene (0, 1, or 2) and the variable (Hlf + Tef) represented the sum of the number of Hlf and Tef alleles. The column p > F reports the significance of each model assessed from an F test. For models that accounted for >10% of the variance in the data (adj R2 > 0.1; bold values), the intercept (b0) and coefficients (b1…) are listed, along with the 790 probability that the coefficient is nonzero (t test).

Model (TTX) Adj R2 Pr > F b0 (Pr > t) b1 (Pr > t) b2 (Pr > t) b3 (Pr > t)
1 PF = b0 + b1(Hlf) + b2(Tef) + b3(Dbp) 0.284 2E−07 0.457 (<2E−16) –0.055 (0.003) –0.068 (4E−4) 0.006 (0.71)
2 PF = b0 + b1(Hlf) 0.198 4E−06 0.423 (<2E−16) –0.081 (4E−6)
3 PF = b0 + b1(Tef) 0.229 4E−07 0.437 (<2E−16) –0.088 (4E−7)
4 PF = b0 + b1(Dbp) 0.073 0.007
5 PF = b0+b1(Hlf) + b2(Tef) 0.291 3E−08 0.458 (<2E−16) –0.052 (0.003) –0.066 (2E−4)
6 PF = b0 + b1(Hlf + Tef) 0.296 4E−09 0.485 (<2E−16) –0.059 (4E−9)
Model (Ctrl)
7 PF = b0 + b1(Hlf) + b2(Tef) + b3(Dbp) 0.044 0.08
8 PF = b0 + b1(Hlf) –0.01 0.84
9 PF = b0 + b1(Tef) 0.005 0.52
10 PF = b0 + b1(Dbp) 0.063 0.05
11 PF = b0 + b1(Hlf) + b2(Tef) –0.01 0.62
12 PF = b0 + b1(Hlf + Tef) –0.01 0.80
  1. All of the models produced poor fits (adjusted R2 of –0.01 to 0.063) to the control data, consistent with the hypothesis that baseline activity does not depend on genotype.

  2. All of the models that included variables for Hlf and/or Tef produced much better fits to the TTX data (adjusted R2 of 0.198–0.296) consistent with the hypothesis that rebound activity is influenced by genotype. In these models, the coefficients (effect size) for Hlf and Tef were similar and t tests revealed they were highly significantly different from 0.

  3. The model that only depended on Dbp (line 4) provided a poor fit to the TTX data (adjusted R2 = 0.073) and in the model that included both terms for Dbp and the other two factors (line 1), the Dbp coefficient was small and not significantly different from 0. These observations are consistent with the hypothesis that rebound activity does not depend on Dbp and that even in a significant model including Hlf and Tef, Dbp does not add additional explanatory power to the model.

  4. The models that included terms for both Hlf and Tef (line 5) or for their sum (line 6) produced the best fits (adjusted R2 = 0.291 and 0.296); that is, better than those that depend on only one of these factors (lines 2 and 3; adjusted R2 = 0.198 and 0.229). This is consistent with the hypothesis that both genes contribute to constraining cortical homeostatic plasticity.

Since the model with the highest adjusted R2 was that which depended only on the sum of the number of Hlf and Tef alleles (line 6), we used this model for further post hoc (Tukey) tests to determine the effect of different numbers of alleles on the TTX response. The results of this analysis are shown in Figure 6. The most significant differences were between TKO slices (0 alleles; n = 32, mean = 0.48) and the other genotypes tested (1 allele, n = 16, mean = 0.32; 2 alleles, n = 26, mean = 0.35; and 4 alleles, n = 24, mean = 0.23; p < 0.0001–0.0014). Most of the other comparisons were not significant, with the exception of the difference between WT responses and those for animals with only two alleles (p = 0.011). This indicates that most of the difference between TKO (0 alleles of Hlf + Tef) and WT (4 alleles of Hlf + Tef) could be restored by a single allele, although there was a small but significant improvement between two and four alleles. The fact that this difference was significant, but the differences between 1 and 2 alleles, and 1 and 4 alleles were not, may reflect a real difference between these groups, or may reflect the imbalanced numbers of animals in each group. The group with two alleles included animals that were WT for Hlf but lacked Tef (N = 8), animals that were WT for Tef and lacked Hlf (N = 9), and trans-Het animals that were heterozygous for both Hlf and Tef (N = 7). A separate analysis of variance of these three subgroups revealed that the means (0.32, 0.41, and 0.33) were not significantly different (p = 0.28), consistent with the hypothesis that alleles of Hlf and Tef can substitute for one another in their ability to regulate the homeostatic response to activity deprivation.

Figure 6. Presence of one allele of Hlf or Tef largely restores the WT response to activity deprivation.

Figure 6.

Violin plots show the distribution of peak frequencies measured from TTX-treated (upper, darker colors, filled symbols) and control (lower, lighter colors, open symbols) slice cultures made from animals carrying 0, 1, 2, or 4 alleles of the PARbZIP TFs Hlf and Tef. Data are those used in Table 1 with the X-axis corresponding to models 6 (TTX) and 12 (Control). Horizontal positions of individual data points are jittered to prevent overplotting. Horizontal lines at top indicate results of post hoc t tests between levels for the TTX data with Tukey correction for multiple comparisons. *adj. p < 0.05, **adj. p < 0.01, ***adj. p < 0.001, N.S. – not significant, adj. p > 0.05. No post hoc testing was performed for the Control data since the fit of model 12 was not significant. WT, wild-type.

Figure 6—source data 1. Calcium imaging analysis summary, 2D, 5D TTX; all genotypes.

To further dissect the relative contribution of the Par bZIP family members, we measured the survival of the mice with different numbers of copies of the TFs. TKO animals develop spontaneous seizures and have a dramatically decreased lifespan (Gachon et al., 2004). While our objective was not to make a detailed study of the seizure phenotype, we also observed, on multiple occasions, TKO animals that experienced spontaneous seizures, even though for most of cases, the instance of death was not directly observed. However, just one allele of either Hlf or Tef restores the lifespan of the animals to levels not statistically different from WT. Mice with one Dbp allele have improved survival compared to TKO animals but still die at a statistically significant higher rate than WT mice (Figure 7). These results differ from the cortical network activity response to activity deprivation in organotypic slices where the presence of Dbp had no effect on the constraint of homeostatic plasticity. This suggests that even though Dbp is dispensable for restraining homeostatic plasticity in the cortex, it may play a role in preventing premature death by functioning elsewhere in the brain or peripheral tissue (Stewart et al., 2020) since these TFs are expressed and play important roles there (Wahlestedt et al., 2017; Wang et al., 2010). However, a single allele of Hlf and Tef is enough to compensate for loss of the rest of the family members and restore survival to WT levels.

Figure 7. Presence of one allele of a PARbZIP TF improves survival relative to TKO animals.

Figure 7.

TKO mice have dramatically decreased survival (red line) compared to wild-type (WT) mice (black line). Presence of one copy of either Hlf (green line) or Tef (purple line) prevents premature death and the survival curves are not statistically different from WT, p = 0.12 and p = 0.56, respectively, Log-rank test with Bonferroni correction for multiple comparisons. DBP heterozygous mice (blue line) also have improved survival over TKO mice (p = 0.003) but are still statistically more likely to die prematurely than WT mice (p = 0.0003). N = 59 for DBP heterozygous, N = 96 for TKO, N = 36 for HLF heterozygous, N = 23 for WT, and N = 179 for TEF heterozygous. TKO, triple knockout.

Figure 7—source data 1. Survival data by genotype.
Figure 7—source data 2. Statistical analysis of survival data.

Discussion

Inappropriately triggered homeostatic plasticity can either fail to compensate for changes in activity or can itself destabilize network activity (Nelson and Valakh, 2015). Although some molecular pathways that are required for the induction of homeostatic plasticity have been identified, whether and how homeostatic plasticity is negatively regulated is unknown. Here, we show that reduced activity, which initiates a compensatory increase in network excitability, also activates a set of TFs that function to restrain homeostasis. Thus, we propose a model in which homeostatic plasticity is negatively regulated through the PARbZIP family of TFs.

Excitatory neurons respond to a global drop in network activity by upregulating the frequency and amplitude of excitatory synaptic currents, decreasing inhibitory currents, and increasing intrinsic excitability. These changes correlate with dramatically increased network activity immediately following removal of activity blockade that ‘overshoots’ initial activity levels. Synaptic scaling of excitatory synapses has previously been shown to depend on intact transcription and translation (Dörrbaum et al., 2020; Goold and Nicoll, 2010; Ibata et al., 2008; Schanzenbächer et al., 2016). Here, we demonstrate a second role for transcription in regulating the strength of the network homeostatic response. Loss of Hlf, Tef, and Dbp results in exaggerated homeostatic changes. However, the levels of network activity at baseline are unchanged. This suggests that these TFs are activated to restrain homeostatic signaling rather than downregulating network dynamics directly. While a few other genes have been described that have limited effects on network dynamics, but are required for homeostatic plasticity (Shank3, Tatavarty et al., 2020; FMRP, Soden and Chen, 2010; and Caspr2, Fernandes et al., 2019), this is, to our knowledge, the first negative regulator of homeostasis to be described.

Present data implicate mEPSC frequency, but not amplitude, as the site of the restraint of homeostatic plasticity. Although 2 days of activity blockade in dissociated cortical cultures were initially found to produce scaling up of EPSC amplitudes without accompanying changes in mEPSC frequency (Turrigiano et al., 1998), multiple subsequent studies have found evidence for changes in both amplitude and frequency as found here (Echegoyen et al., 2007; Koch et al., 2010; Thiagarajan et al., 2005; Wierenga et al., 2006). Changes in mini frequency are typically interpreted as reflecting increased presynaptic release, either via increases in the numbers of synapses or active release sites, or via changes in the rate at which spontaneous, action potential independent release occurs at each site. Although the increase observed in mEPSC frequency (1.7-fold greater in TKO than WT), was lower than the relative increase in activity levels, measured from the frequency of calcium transients (2.5-fold greater in TKO than WT at 5 days), these two measures need not be linearly related. First, mini frequency can be distinct from action potential evoked release (Crawford et al., 2017), and second, in a highly recurrent network, the relationship between firing and synaptic strength can be nonlinear (Toyoizumi and Abbott, 2011). We cannot eliminate the contribution of inhibitory neurons as a contributing factor to homeostatic plasticity restraint, since Hlf and Tef are expressed in this neuronal type and are also upregulated by inactivity. Interneuron function may also be regulated by Hlf and Tef and this role may predispose the network to seizures. Dissecting the contribution of different cell types during different developmental windows will require generation of a conditional knockout and selective cell-type-specific disruption of individual TFs at different times in development.

mIPSCs received by excitatory neurons cannot explain the exaggerated network hyperexcitability caused by TTX incubation in TKO slices since neither the amplitude nor frequency of mIPSCs is different in the TTX condition. We note, however, that the amplitude of mIPSCs is decreased at baseline in the untreated cultures. Such decrease of the strength of inhibitory currents is insufficient on its own to induce network excitability, since baseline network activity was unchanged in the TKO, but it may make the network more vulnerable to future insults.

It is tempting to imagine a direct relationship between the exaggerated homeostatic plasticity in TKO cortical slices and the increased seizures and spontaneous death of TKO animals. The lack of constraint of homeostatic response can potentially explain, at least in part, the seizure phenotype in animals lacking all three TFs. However, partial genetic compensation of DBP for the survival phenotype but not the homeostatic plasticity phenotype as assayed by calcium imaging, suggests that the propensity to develop seizures and diminished survival have a more complex origin involving other brain regions and perhaps other organs of the body.

Gachon et al., 2004 first reported that deletion of the PARbZIP proteins TEF, HLF, and DBP caused spontaneous and audiogenic seizures. They suggested that this may reflect effects on neurotransmitter metabolism caused by a reduction in pyridoxal phosphate (PLP) since pyridoxal kinase, which catalyzes the last step in the conversion of vitamin B6 into PLP is a target of the PARbZIP proteins. PLP is a required cofactor for decarboxylases and other enzymes involved in the synthesis and metabolism of GABA, glutamate, and the biogenic amine neurotransmitters including dopamine, serotonin, and histamine. Using HPLC, they found no changes in GABA or glutamate, but reduced levels of dopamine, serotonin, and histamine in the knockout animals. Although changes in amine transmitters could potentially contribute to phenotypes in vivo, they are unlikely to contribute to plasticity in cortical slice cultures which do not include the brainstem nuclei from which these projections arise. Reduced glutamate decarboxylase action could potentially have contributed to the observed baseline reduction in mIPSCs since heterozygous (Lazarus et al., 2015) and homozygous (Lau and Murthy, 2012) mutants of Gad1, the gene encoding the GAD67 isoform of glutamic acid decarboxylase, have reduced mIPSC amplitudes. However, this does not account for the enhanced homeostatic overshoot following activity blockade, since in the TKO animals, activity blockade did not produce any further reduction in inhibition, but produced robust changes at excitatory synapses.

HLF and TEF form homo- or heterodimers and recognize similar DNA sequences (Gachon, 2007). Here, we demonstrate that these TFs can powerfully compensate for the loss of other family members. We varied genotype for all three PARbZip factors and used multiple regression models to show that the peak frequency of calcium transients depends roughly equally on Hlf and Tef but does not appear to depend on Dbp. It also appears that a single allele of either Hlf or Tef in the complete absence of the other factors is sufficient to preserve the normal restraint of homeostatic plasticity, producing a response to activity deprivation that is not significantly different from WT. However, given the large number of genotypes to be tested, the limited number of animals tested may have led us to miss subtle difference that varies with the number of additional alleles, since activity in the presence of two alleles was significantly different (albeit with a low effect size) from that in WT. We also found, in agreement with prior findings (Gachon et al., 2004), that Tef and Hlf can robustly compensate for loss of each other and completely restore life span. Such robust compensation and functional redundancy of these TFs highlight their importance and may explain why they have not been identified in GWAS studies as risk factors for epilepsy or other neuropsychiatric diseases.

The mechanisms linking activity deprivation to Tef and Hlf activation were not directly addressed in this work, but seem likely to depend on reduced calcium influx. Prior studies have suggested alternately that scaling up of mEPSC amplitudes depends upon calcium influx through either T-type (Schaukowitch et al., 2017) or L-type (Li et al., 2020) calcium channels. The former pathway has also been found to depend on the activity-dependent TFs ELK1 and SRF. Activation of the constraining TFs Tef and Hlf could be secondary or delayed responses dependent on changes in the transcription and translation of other activity-dependent TFs, or may represent a primary response to activity deprivation, analogous to, but in the opposite direction of the well-studied immediate early genes such as Fos, Arc, and others.

Besides their function in early embryonic development (Gavriouchkina et al., 2010; Wahlestedt et al., 2017), the PARbZip TFs have been extensively studied for their roles in circadian rhythms in flies, zebrafish, and rodents (Cyran et al., 2003; Vatine et al., 2009; Weger et al., 2021). The present finding that Hlf and Tef also act to restrain homeostatic plasticity is consistent with a recent report demonstrating that PARbZIP TFs are differentially expressed in human epileptogenic tissue (Rambousek et al., 2020). In addition, CLOCK, an upstream regulator of these TFs, is necessary in cortical excitatory neurons for maintaining normal network activity and leads to epilepsy when conditionally deleted in these neurons (Li et al., 2017). Multiple components of the molecular clock are robustly expressed in the neocortex (Bering et al., 2018; Gachon et al., 2004; Kobayashi et al., 2015), consistent with the idea that they might have an additional function in the cortex that is distinct from their circadian role in SCN. However, the role of core clock genes in homeostatic plasticity has not yet been explored. In this work, we expand the role of the PARbZIP family of TFs to include the negative regulation of homeostatic plasticity.

Why should homeostatic plasticity be subject to such dual ‘push/pull’ regulation? Perhaps because the changes in drive and excitability which must be buffered vary so widely during development. During the first few weeks of postnatal development in rodents, cortical neurons go from receiving few synapses to receiving thousands. This may require developmental downregulation of the strength of homeostatic plasticity. Neuropsychiatric diseases, such as monogenic causes of ASD, can trigger homeostatic changes in circuit properties which restore overall firing rates, but nonetheless have maladaptive effects on cortical function and flexibility (Antoine et al., 2019; Nelson and Valakh, 2015). Conversely, loss of function of genes giving rise to developmental disorders can cause failures of homeostatic plasticity (Blackman et al., 2012; Genç et al., 2020). Our findings provide a potential target for enhancing homeostatic plasticity in contexts where it is insufficient, or for downregulating it when it is maladaptive, and therefore provide an avenue for identifying how the positive and negative regulators of homeostasis interact to stabilize network activity.

Materials and methods

Key resources table.

Reagent type (species) or resource Designation Source or reference Identifiers Additional information
Gene (Mus musculus) Hlf MGI MGI:MGI:96108
Gene (Mm) Tef MGI MGI:MGI:98663
Gene (Mm) Dbp MGI MGI:MGI:94866
Strain, strain background (Mm) Emx1-ires-Cre Jackson Labs JAX:005628
Strain, strain background (Mm) Pvalb-ires-Cre Jackson Labs JAX:017320
Strain, strain background (Mm) triple knockout (TKO) Hlf−/−/Dbp−/−/Tef−/; TKO Jackson Labs EM:02489
Strain, strain background (Mm) Ai9 Jackson Labs JAX:007909
Cell line (include species here)
Transfected construct (include species here)
Biological sample (include species here)
Antibody (Include host species and clonality) (Include dilution)
Recombinant DNA reagent AAV-GCaMP6f Addgene pAAV.Syn.GCaMP6f.WPRE.SV40 (AAV9 capsid serotype)
100837
Sequence-based reagent RPL10 Forward This paper PCR primers 5′-CACGGCAGAAACGAGACTTT-3′
Sequence-based reagent RPL10 Reverse This paper PCR primers 5′-CACGGACGATCCTATTGTCA-3′
Sequence-based reagent GAPDH (forward) This paper PCR primers 5′-TCAATGAAGGGGTCGTTGAT-3′
Sequence-based reagent GAPDH (reverse) This paper PCR primers 5′-CGTCCCGTAGACAAAATGGT-3′
Sequence-based reagent HLF (forward) This paper PCR primers 5′-CGGTCATGGATCTCAGCAG-3′
Sequence-based reagent HLF (reverse) This paper PCR primers 5′-GTACCTGGATGGTGTCAGGG-3′
Sequence-based reagent TEF (forward) This paper PCR primers 5′-GAGCATTCTTTGCCTTGGTC-3′
Sequence-based reagent TEF (reverse) This paper PCR primers 5′-GGATGGTCTTGTCCCAGATG-3′
Peptide, recombinant protein
Commercial assay or kit Ovation RNA-seq system Nugen
Commercial assay or kit Illumina library quantification kit KAPA biosystems
Commercial assay or kit Picopure RNA isolation kit Life Technologies
Commercial assay or kit iScript cDNA Synthesis Kit Bio-Rad #1708891
Commercial assay or kit RNA Clean and Concentrator kit Zymo Research R1014
Commercial assay or kit SYBR Green Supermix Bio-Rad 1725270
Chemical compound, drug Tetrototoxin (TTX) Abcam ab120055
Chemical compound, drug DNQX Sigma-Aldrich D0540
Chemical compound, drug APV R&D Systems 0106
Chemical compound, drug Picrotoxin (PTX) R&D Systems 1128
Software, algorithm Calcium Imaging Analysis Code https://github.com/VH-Lab/vhlab-TwoPhoton-matlab; copy archived at Van Hooser, 2023
Software, algorithm MatLab Mathworks https://www.mathworks.com/products/matlab.html RRID:SCR_001622
Software, algorithm IgorPro WaveMetrics https://www.wavemetrics.com/ RRID:SCR_000325
Software, algorithm GraphPad PRISM GraphPad Software
https://www.graphpad.com/
RRID:SCR_002798
Software, algorithm STAR https://github.com/alexdobin/STAR;
Dobin, 2023
Software, algorithm featureCounts (Rsubread package) https://bioconductor.org/packages/release/bioc/html/Rsubread.html
Software, algorithm DESeq2 https://bioconductor.org/packages/release/bioc/html/DESeq2.html

Animals

All procedures were approved by the Institutional Animal Care and Use Committee at Brandeis University (Protocol #20002), and conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The initial RNAseq screen (Figure 1) was performed using the Cre-dependent tdTomato reporter strain Ai9 (Madisen et al., 2010) crossed with either parvalbumin-ires-Cre (Hippenmeyer et al., 2005), or Emx1-ires-Cre animals (Gorski et al., 2002) obtained from Jackson Labs. All other experiments were performed using WT (C57BL/6J) and previously published TKO Hlf−/−/Dbp−/−/Tef−/ animals (Gachon et al., 2004) which were acquired from the European Mouse Mutant Archive (stock EM:02489) as frozen embryos and propagated via IVF using a provider-recommended protocol. TKO mice were housed on a 12/12 light/dark cycle in a dedicated, climate-controlled facility. Cages were enriched with huts, chew sticks, and tubes. Food and water were available ad libitum, and animals were housed in groups of 2–4 after weaning at p21. Mice of both sexes were used for experiments.

Organotypic slice culture

Organotypic slices were dissected from P6 to P8 pups. Animals were anesthetized with a ketamine (20 mg/mL), xylazine (2.5 mg/mL), and acepromazine (0.5 mg/mL) mixture (40 μL, via intraperitoneal injection), the brain was extracted, embedded in 2% agarose, and coronal slices containing primary somatosensory cortex were cut on a compresstome (Precisionary Instruments, Greenville, NC) to 300 μm in ice-chilled ACSF (126 mM NaCl, 25 mM NaHCO3, 3 mM KCl, 1 mM NaH2PO4, 25 mM dextrose, 2 mM CaCl2, and 2 mM MgCl2, 315–319 mOsm) with a ceramic blade and placed directly onto six-well Millipore Millicell cell culture inserts (Millipore Sigma PICM0RG50, Burlington, MA) over 1 mL warmed neuronal media (1× MEM (Millipore-Sigma), 1× GLUTAMAX (Gibco Thermo Fisher Scientific), 1 mM CaCl2, 2 mM MgSO4, 12.9 mM dextrose, 0.08% ascorbic acid, 18 mM NaHCO3, 35 mM 1 M HEPES (pH 7.5), 1 µg/mL insulin and 20% Horse Serum (heat inactivated, Millipore Sigma, Burlington, MA), pH 7.45 and 305 mOsm). Slices were placed in media containing 1× PenStrep (Gibco Thermo Fisher Scientific) and 50 µg/mL gentamicin (Millipore Sigma) for 24 hr and subsequent media changes were antibiotic-free. The slices were then grown at 35°C and 5% CO2. Media were changed every other day to 1 mL of fresh media. For TTX treatment, media containing 500 nM TTX was added during the media change at EP 12. For TTX washout experiments, two additional media changes with TTX-free media were performed 5 min apart.

RNA-sequencing

Cell sorting

Slice cultures were converted into a single-cell suspension as previously described (Sugino et al., 2006), with some modifications. Organotypic slice cultures (n = 3 from three separate animals per condition) were placed in ice-cold, oxygenated ACSF with 1% FBS, and 5% Trehalose (Saxena et al., 2012), that had been 0.4 μm filtered, containing blockers (APV, DNQX, and TTX) to prevent excitotoxicity, and gently removed from the membrane. The cortex was micro-dissected under a Leica MZ 16F fluorescent microscope and the tissue was placed in an oxygenated room temperature bath for 45 min, supplemented with 1 mg/mL type XIV protease (Sigma-Aldrich). Afterward, the tissue was moved back to the ACSF solution (without protease) and triturated with fire-polished Pasteur pipettes of successfully smaller diameters (~600, 300, and 150 μm). Samples were then sorted with a BD FACSAria Flow Cytometer. All isolated material for mRNA sequencing was harvested using the picopure RNA isolation kit (Life Technologies) and subjected to an one column DNAase digestion. mRNA libraries were prepared as previously described (O’Toole et al., 2017): amplifying with the Ovation RNA-seq system (Nugen), sonicating with a Covaris S 220 Shearing Device, constructing the libraries with the Ovation Rapid DR multiplex System (Nugen), and quantifying library concentration using the Illumina library quantification kit (KAPA biosystems). Samples were sequenced on either the Illumina Nextseq or Hiseq machines to a depth of ~25 million reads. Illumina sequencing adapters were trimmed from reads using cutadapt followed by mapping to the mm10 genome with STAR using the ENCODE Long RNA-Seq pipeline’s parameters. Reads mapping to exons of known genes were quantified using featureCounts in the Rsubread package (Liao et al., 2019) and differential expression analysis was conducted using DESeq2 (Love et al., 2014). One of the three Emx1-cre TTX replicates was severely contaminated (high levels of nonneuronal genes and low enrichment of neuronal genes) and was excluded. Adjusted p values for each gene are reported from a Wald Test evaluating the significance of the coefficient representing the treatment group (TTX or Control) followed by the Benjamini-Hochberg correction.

Quantitative real-time PCR

RNA was extracted from neocortical regions of slice cultures using TRIzol reagent followed by RNA Clean and Concentrator Kit (Zymo Research R1014). cDNA was synthesized with 0.5 µg of RNA using the cDNA Synthesis Kit (Bio-Rad 170-8891) using random hexamers to generate cDNA from total RNA. Quantitative real-time PCR was performed using Corbett Research RG-6000 Real-Time PCR Thermocycler with SYBR Green Supermix (Bio-Rad). The following primer sequences were used: RPL10 (forward) 5′-CACGGCAGAAACGAGACTTT-3′, RPL10 (reverse) 5′-CACGGACGATCCTATTGTCA-3′, GAPDH (forward) 5′-TCAATGAAGGGGTCGTTGAT-3′ GAPDH (reverse) 5′-CGTCCCGTAGACAAAATGGT-3′, HLF (forward) 5′-CGGTCATGGATCTCAGCAG-3′, HLF (reverse) 5′-GTACCTGGATGGTGTCAGGG-3′, TEF (forward) 5′-GAGCATTCTTTGCCTTGGTC-3′, and TEF (reverse) 5′-GGATGGTCTTGTCCCAGATG-3′.

Electrophysiology

Organotypic slice cultures were cut out of the cell culture inserts along with the membrane using a scalpel blade. Slices were transferred to a thermo-regulated recording chamber and continuously perfused with oxygenated ACSF. Neurons were visualized on an Olympus upright epifluorescence microscope with 10× air and 40× water immersion objectives. Visually guided whole-cell patch-clamp recordings were made using near-infrared differential interference contrast microscopy. Recording pipettes of 3–5 MΩ resistance contained internal solution with the following concentrations. For excitatory currents and intrinsic excitability: (in mM) 20 KCl, 100 K-gluconate, 10 HEPES, 4 Mg-ATP, 0.3 Na-GTP, 10 Na-phosphocreatine, and 0.1% biocytin. For inhibitory currents: (in mM) 120 KCl, 10 HEPES, 4 Mg-ATP, 0.3 Na-GTP, 10 Na-phosphocreatine, and 0.1% biocytin. Recordings were collected using an AxoPatch 200B amplifier (Axon Instruments, Foster City, CA), filtered at 10 kHz and were not corrected for liquid junction potentials. Data were collected on a Dell computer using custom software running on Igor Pro (WaveMetrics, Lake Oswego, OR).

Intrinsic excitability

Cells were selected at random from layer 5 in primary somatosensory cortex. Whole-cell recordings were performed with a K-Gluconate-based internal recording solution. Synaptic currents were blocked by adding picrotoxin (PTX) at 25 μM, 6,7-dinitroquinoxaline-2,3-dione (DNQX) 25 μM, and (2R)-amino-5-phosphonovaleric acid (APV) at 35 μM to standard ACSF to block γ-aminobutyric acid (GABA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and N-methyl-d-aspartate (NMDA) receptors, respectively. Cells were held at –65 mV by injecting a small current. 500 ms current injections ranging from –25 to 275 pA in 25 pA steps increments at random intensity were delivered every 10 s. Adaptation ratio was calculated using custom-written IGOR script as previously described (Hattox and Nelson, 2007). Briefly, we calculated the ratio between the third and last inter-spike interval at two times the threshold current.

Synaptic currents

To isolated miniature excitatory AMPA-mediated currents 25 µM PTX, 35 µM APV, and 500 nM TTX were added to the extracellular recording solution. To isolate inhibitory currents, 20 µM DNQX, 35 µM APV, and 500 nM TTX were added to the extracellular solution. The slices were incubated in TTX only during active recording, which lasted no more than 30 min for each slice. Cells were clamped at –65 mV with a series resistance of below 20 MΩ with no compensation for the liquid junction potential. Ten 10-s traces were acquired for each cell. Threshold-based detection of mPSCs and action potentials was implemented using custom-written IGOR scripts equipped with routines for baseline subtraction, custom filtering, and measurements of intervals, amplitudes, and kinetic properties.

Calcium imaging

To visualize calcium dynamics, 24 hr after slice preparation, 1 µL of pAAV.Syn.GCaMP6f.WPRE.SV40 (AAV9 capsid serotype, Addgene 100837) was applied to the somatosensory cortex in each hemisphere. At day EP14, slices were cut out along with the membrane and placed into the perfusion chamber mounted on a spinning disc microscope (Leica DMI 6000B; Leica Microsystems, Inc, Buffalo Grove, IL), with an Andor CSU W1 spinning disc unit, using an Andor Neo sCMOS cameras and Andor IQ3 to run the system (Andor Technology PLC, Belfast, N. Ireland). Slices were allowed to acclimate while being perfused with 33°C oxygenated ACSF with no TTX for 10 min. Slices were imaged with a 10× objective centered over the primary somatosensory area. For each slice, 10 min of imaging from a 500-µm square per slice were acquired at 33 frames per second.

Calcium imaging analysis

Cellular somatic ROIs were selected by hand from background using custom MATLAB code (http://github.com/VH-Lab/vhlab-TwoPhoton-matlab) (Van Hooser, 2023) based on a standard deviation projection of the video (Figure 1A, bottom panel). Cells were only considered viable if they: were of a characteristic size and shape for neurons; were bright enough to be clearly distinguished from background; were in focus with clear and sharp edges; and had several bouts of firing within the first minute. Active cells (n = 10–100) were selected by the experimenter within our area of imaging. We confirmed by subsampling cells in a subset of WT control experiments with more cells (n = 7 slices with 27–43 cells) that for the lowest sample of cells measured (n = 10), the estimates of peak frequency and synchrony had a coefficient of variation of the mean (SEM/mean calculated across sub-samples within a slice) of 0.05 and 0.01. From these ROIs, mean intensity per cell at each frame was computed. The raw intensity values were transformed to ΔF/F by diving by baseline values obtained either where the coefficient of variation within 50 frames was below 0.3 ΔF/F units/frame, or from the 5th percentile of all frames. Since the distribution of event amplitudes across cells was potentially dependent on other experimental factors such as the amount of calcium indicator expressed as well as optical factors such as the depth of the cell in the slice, we decided not to try to infer the magnitude of firing from the amplitude of events, but only periods of elevated firing from the timing of events. To produce a peak frequency measure, noise was reduced by fitting the ΔF/F data with a smoothing spline, and active periods were defined as those with a slope above 0.30 ΔF/F units/frame that were within 30 frames of other frames with positive slope. The number of active periods reflected the number of times each cell was active, though this measure had no ability to predict the number of action potentials that made up each firing period. We excluded cells that failed to fire at any time during our period of recording. In addition, some of our slices exhibited some dimming of signal due to a combination of drift in the Z-dimension and fluorescent photobleaching. Experiments were discarded if this decrement caused firing peaks to fall and remain below the slope threshold in the selected cells. Synchrony was defined as the cross-correlation at delta T = 0 during upstates computed for all pairs of recorded cells and averaged across cells and across upstates.

Acknowledgements

This research was supported by the National Institute of Neurological Disease and Stroke and by the Simons Foundation for Autism Research.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Sacha B Nelson, Email: nelson@brandeis.edu.

Yukiko Goda, Okinawa Institute of Science and Technology Graduate University, Japan.

Gary L Westbrook, Oregon Health & Science University, United States.

Funding Information

This paper was supported by the following grants:

  • National Institute of Neurological Disorders and Stroke R01NS109916 to Sacha B Nelson.

  • Simons Foundation Autism Research Initiative 648651 to Sacha B Nelson.

Additional information

Competing interests

No competing interests declared.

Reviewing editor, eLife.

Author contributions

Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing.

Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing - review and editing.

Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - review and editing.

Data curation, Formal analysis, Investigation, Writing - review and editing.

Data curation, Formal analysis, Investigation, Writing - review and editing.

Software, Formal analysis, Writing - review and editing.

Data curation, Formal analysis, Validation, Investigation, Writing - review and editing.

Data curation, Formal analysis, Validation, Investigation, Visualization, Writing - review and editing.

Data curation, Software, Formal analysis, Validation, Visualization, Writing - review and editing.

Formal analysis, Investigation, Writing - review and editing.

Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Visualization, Writing - original draft, Project administration, Writing - review and editing.

Ethics

All procedures were approved by the Institutional Animal Care and Use Committee at Brandeis University (Protocol #20002), and conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals.

Additional files

MDAR checklist

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files, calcium imaging analysis code is available https://github.com/VH-Lab/vhlab-TwoPhoton-matlab (copy archived at Van Hooser, 2023). RNAseq data have been deposited to the BioSample database under accession numbers: SAMN31104764, SAMN31104765, SAMN31104766, SAMN31104767, SAMN31104768, SAMN31104769, SAMN31104770, SAMN31104771, SAMN31104772, SAMN31104773, SAMN31104774, and SAMN31104775.

The following datasets were generated:

Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104764

Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104765

Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104766

Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104767

Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104768

Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104769

Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104770

Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104771

Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104772

Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104773

Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104774

Nelson S, Velakh S, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104775

References

  1. Antoine MW, Langberg T, Schnepel P, Feldman DE. Increased excitation-inhibition ratio stabilizes synapse and circuit excitability in four autism mouse models. Neuron. 2019;101:648–661. doi: 10.1016/j.neuron.2018.12.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bering T, Carstensen MB, Wörtwein G, Weikop P, Rath MF. The circadian oscillator of the cerebral cortex: molecular, biochemical and behavioral effects of deleting the arntl clock gene in cortical neurons. Cerebral Cortex. 2018;28:644–657. doi: 10.1093/cercor/bhw406. [DOI] [PubMed] [Google Scholar]
  3. Blackman MP, Djukic B, Nelson SB, Turrigiano GG. A critical and cell-autonomous role for mecp2 in synaptic scaling up. The Journal of Neuroscience. 2012;32:13529–13536. doi: 10.1523/JNEUROSCI.3077-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crawford DC, Ramirez DMO, Trauterman B, Monteggia LM, Kavalali ET. Selective molecular impairment of spontaneous neurotransmission modulates synaptic efficacy. Nature Communications. 2017;8:14436. doi: 10.1038/ncomms14436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cyran SA, Buchsbaum AM, Reddy KL, Lin MC, Glossop NRJ, Hardin PE, Young MW, Storti RV, Blau J. Vrille, pdp1, and dclock form a second feedback loop in the Drosophila circadian clock. Cell. 2003;112:329–341. doi: 10.1016/s0092-8674(03)00074-6. [DOI] [PubMed] [Google Scholar]
  6. Davis GW. Homeostatic control of neural activity: from phenomenology to molecular design. Annual Review of Neuroscience. 2006;29:307–323. doi: 10.1146/annurev.neuro.28.061604.135751. [DOI] [PubMed] [Google Scholar]
  7. Delvendahl I, Müller M. Homeostatic plasticity-a presynaptic perspective. Current Opinion in Neurobiology. 2019;54:155–162. doi: 10.1016/j.conb.2018.10.003. [DOI] [PubMed] [Google Scholar]
  8. Desai NS, Rutherford LC, Turrigiano GG. Plasticity in the intrinsic excitability of cortical pyramidal neurons. Nature Neuroscience. 1999;2:515–520. doi: 10.1038/9165. [DOI] [PubMed] [Google Scholar]
  9. Desai NS, Cudmore RH, Nelson SB, Turrigiano GG. Critical periods for experience-dependent synaptic scaling in visual cortex. Nature Neuroscience. 2002;5:783–789. doi: 10.1038/nn878. [DOI] [PubMed] [Google Scholar]
  10. Dobin A. STAR. GitHub. 2023 https://github.com/alexdobin/STAR
  11. Dörrbaum AR, Alvarez-Castelao B, Nassim-Assir B, Langer JD, Schuman EM. Proteome dynamics during homeostatic scaling in cultured neurons. eLife. 2020;9:e52939. doi: 10.7554/eLife.52939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Echegoyen J, Neu A, Graber KD, Soltesz I. Homeostatic plasticity studied using in vivo hippocampal activity-blockade: synaptic scaling, intrinsic plasticity and age-dependence. PLOS ONE. 2007;2:e700. doi: 10.1371/journal.pone.0000700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fernandes D, Santos SD, Coutinho E, Whitt JL, Beltrão N, Rondão T, Leite MI, Buckley C, Lee HK, Carvalho AL. Disrupted AMPA receptor function upon genetic- or antibody-mediated loss of autism-associated CASPR2. Cerebral Cortex New York, N.Y. 2019;29:4919–4931. doi: 10.1093/cercor/bhz032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gachon F, Fonjallaz P, Damiola F, Gos P, Kodama T, Zakany J, Duboule D, Petit B, Tafti M, Schibler U. The loss of circadian PAR bzip transcription factors results in epilepsy. Genes & Development. 2004;18:1397–1412. doi: 10.1101/gad.301404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gachon F. Physiological function of parbzip circadian clock-controlled transcription factors. Annals of Medicine. 2007;39:562–571. doi: 10.1080/07853890701491034. [DOI] [PubMed] [Google Scholar]
  16. Galvan CD, Hrachovy RA, Smith KL, Swann JW. Blockade of neuronal activity during hippocampal development produces a chronic focal epilepsy in the rat. The Journal of Neuroscience. 2000;20:2904–2916. doi: 10.1523/JNEUROSCI.20-08-02904.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gavriouchkina D, Fischer S, Ivacevic T, Stolte J, Benes V, Dekens MPS. Thyrotroph embryonic factor regulates light-induced transcription of repair genes in zebrafish embryonic cells. PLOS ONE. 2010;5:e12542. doi: 10.1371/journal.pone.0012542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Genç Ö, An JY, Fetter RD, Kulik Y, Zunino G, Sanders SJ, Davis GW. Homeostatic plasticity fails at the intersection of autism-gene mutations and a novel class of common genetic modifiers. eLife. 2020;9:e55775. doi: 10.7554/eLife.55775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Goold CP, Nicoll RA. Single-cell optogenetic excitation drives homeostatic synaptic depression. Neuron. 2010;68:512–528. doi: 10.1016/j.neuron.2010.09.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gorski JA, Talley T, Qiu M, Puelles L, Rubenstein JLR, Jones KR. Cortical excitatory neurons and glia, but not gabaergic neurons, are produced in the emx1-expressing lineage. The Journal of Neuroscience. 2002;22:6309–6314. doi: 10.1523/JNEUROSCI.22-15-06309.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hattox AM, Nelson SB. Layer V neurons in mouse cortex projecting to different targets have distinct physiological properties. Journal of Neurophysiology. 2007;98:3330–3340. doi: 10.1152/jn.00397.2007. [DOI] [PubMed] [Google Scholar]
  22. Hawkins NA, Kearney JA. Confirmation of an epilepsy modifier locus on mouse chromosome 11 and candidate gene analysis by RNA-seq. Genes, Brain, and Behavior. 2012;11:452–460. doi: 10.1111/j.1601-183X.2012.00790.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hawkins NA, Kearney JA. Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations. Epilepsy Research. 2016;119:20–23. doi: 10.1016/j.eplepsyres.2015.11.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hippenmeyer S, Vrieseling E, Sigrist M, Portmann T, Laengle C, Ladle DR, Arber S. A developmental switch in the response of DRG neurons to Ets transcription factor signaling. PLOS Biology. 2005;3:e159. doi: 10.1371/journal.pbio.0030159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hobbiss AF, Ramiro-Cortés Y, Israely I. Homeostatic plasticity scales dendritic spine volumes and changes the threshold and specificity of Hebbian plasticity. IScience. 2018;8:161–174. doi: 10.1016/j.isci.2018.09.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ibata K, Sun Q, Turrigiano GG. Rapid synaptic scaling induced by changes in postsynaptic firing. Neuron. 2008;57:819–826. doi: 10.1016/j.neuron.2008.02.031. [DOI] [PubMed] [Google Scholar]
  27. Johnson HA, Buonomano DV. Development and plasticity of spontaneous activity and up states in cortical organotypic slices. The Journal of Neuroscience. 2007;27:5915–5925. doi: 10.1523/JNEUROSCI.0447-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Karmarkar UR, Buonomano DV. Different forms of homeostatic plasticity are engaged with distinct temporal profiles. The European Journal of Neuroscience. 2006;23:1575–1584. doi: 10.1111/j.1460-9568.2006.04692.x. [DOI] [PubMed] [Google Scholar]
  29. Kilman V, van Rossum MCW, Turrigiano GG. Activity deprivation reduces miniature iPSC amplitude by decreasing the number of postsynaptic GABA (a) receptors clustered at neocortical synapses. The Journal of Neuroscience. 2002;22:1328–1337. doi: 10.1523/JNEUROSCI.22-04-01328.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kim J, Alger BE. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nature Neuroscience. 2010;13:592–600. doi: 10.1038/nn.2517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kobayashi Y, Ye Z, Hensch TK. Clock genes control cortical critical period timing. Neuron. 2015;86:264–275. doi: 10.1016/j.neuron.2015.02.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Koch H, Huh SE, Elsen FP, Carroll MS, Hodge RD, Bedogni F, Turner MS, Hevner RF, Ramirez JM. Prostaglandin E2-induced synaptic plasticity in neocortical networks of organotypic slice cultures. The Journal of Neuroscience. 2010;30:11678–11687. doi: 10.1523/JNEUROSCI.4665-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lambo ME, Turrigiano GG. Synaptic and intrinsic homeostatic mechanisms cooperate to increase L2/3 pyramidal neuron excitability during a late phase of critical period plasticity. The Journal of Neuroscience. 2013;33:8810–8819. doi: 10.1523/JNEUROSCI.4502-12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lau CG, Murthy VN. Activity-Dependent regulation of inhibition via GAD67. The Journal of Neuroscience. 2012;32:8521–8531. doi: 10.1523/JNEUROSCI.1245-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Lazarus MS, Krishnan K, Huang ZJ. Gad67 deficiency in parvalbumin interneurons produces deficits in inhibitory transmission and network disinhibition in mouse prefrontal cortex. Cerebral Cortex. 2015;25:1290–1296. doi: 10.1093/cercor/bht322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Li P, Fu X, Smith NA, Ziobro J, Curiel J, Tenga MJ, Martin B, Freedman S, Cea-Del Rio CA, Oboti L, Tsuchida TN, Oluigbo C, Yaun A, Magge SN, O’Neill B, Kao A, Zelleke TG, Depositario-Cabacar DT, Ghimbovschi S, Knoblach S, Ho C-Y, Corbin JG, Goodkin HP, Vicini S, Huntsman MM, Gaillard WD, Valdez G, Liu JS. Loss of clock results in dysfunction of brain circuits underlying focal epilepsy. Neuron. 2017;96:387–401. doi: 10.1016/j.neuron.2017.09.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Li B, Suutari BS, Sun SD, Luo Z, Wei C, Chenouard N, Mandelberg NJ, Zhang G, Wamsley B, Tian G, Sanchez S, You S, Huang L, Neubert TA, Fishell G, Tsien RW. Neuronal inactivity co-opts LTP machinery to drive potassium channel splicing and homeostatic spike widening. Cell. 2020;181:1547–1565. doi: 10.1016/j.cell.2020.05.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Liao Y, Smyth GK, Shi W. The R package rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Research. 2019;47:e47. doi: 10.1093/nar/gkz114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with deseq2. Genome Biology. 2014;15:550. doi: 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, Zeng H. A robust and high-throughput CRE reporting and characterization system for the whole mouse brain. Nature Neuroscience. 2010;13:133–140. doi: 10.1038/nn.2467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Mitsui S, Yamaguchi S, Matsuo T, Ishida Y, Okamura H. Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism. Genes & Development. 2001;15:995–1006. doi: 10.1101/gad.873501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Moore AR, Richards SE, Kenny K, Royer L, Chan U, Flavahan K, Van Hooser SD, Paradis S. Rem2 stabilizes intrinsic excitability and spontaneous firing in visual circuits. eLife. 2018;7:e33092. doi: 10.7554/eLife.33092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Nelson SB, Valakh V. Excitatory/inhibitory balance and circuit homeostasis in autism spectrum disorders. Neuron. 2015;87:684–698. doi: 10.1016/j.neuron.2015.07.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. O’Toole SM, Ferrer MM, Mekonnen J, Zhang H, Shima Y, Ladle DR, Nelson SB. Dicer maintains the identity and function of proprioceptive sensory neurons. Journal of Neurophysiology. 2017;117:1057–1069. doi: 10.1152/jn.00763.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Rambousek L, Gschwind T, Lafourcade C, Paterna JC, Dib L, Fritschy JM, Fontana A. Aberrant expression of PAR bzip transcription factors is associated with epileptogenesis, focus on hepatic leukemia factor. Scientific Reports. 2020;10:3760. doi: 10.1038/s41598-020-60638-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ripperger JA, Shearman LP, Reppert SM, Schibler U. Clock, an essential pacemaker component, controls expression of the circadian transcription factor DBP. Genes & Development. 2000;14:679–689. doi: 10.1101/gad.14.6.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sanchez-Vives MV, McCormick DA. Cellular and network mechanisms of rhythmic recurrent activity in neocortex. Nature Neuroscience. 2000;3:1027–1034. doi: 10.1038/79848. [DOI] [PubMed] [Google Scholar]
  48. Saxena A, Wagatsuma A, Noro Y, Kuji T, Asaka-Oba A, Watahiki A, Gurnot C, Fagiolini M, Hensch TK, Carninci P. Trehalose-enhanced isolation of neuronal sub-types from adult mouse brain. BioTechniques. 2012;52:381–385. doi: 10.2144/0000113878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Schanzenbächer CT, Sambandan S, Langer JD, Schuman EM. Nascent proteome remodeling following homeostatic scaling at hippocampal synapses. Neuron. 2016;92:358–371. doi: 10.1016/j.neuron.2016.09.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Scharfman H. A novel animal model of epilepsy caused by inhibiting neuronal activity during development. Epilepsy Currents. 2002;2:127–128. doi: 10.1111/j.1535-7597.2002.t01-1-00048.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Schaukowitch K, Reese AL, Kim SK, Kilaru G, Joo JY, Kavalali ET, Kim TK. An intrinsic transcriptional program underlying synaptic scaling during activity suppression. Cell Reports. 2017;18:1512–1526. doi: 10.1016/j.celrep.2017.01.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Soden ME, Chen L. Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid. The Journal of Neuroscience. 2010;30:16910–16921. doi: 10.1523/JNEUROSCI.3660-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature. 2006;440:1054–1059. doi: 10.1038/nature04671. [DOI] [PubMed] [Google Scholar]
  54. Stewart M, Silverman JB, Sundaram K, Kollmar R. Causes and effects contributing to sudden death in epilepsy and the rationale for prevention and intervention. Frontiers in Neurology. 2020;11:765. doi: 10.3389/fneur.2020.00765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Styr B, Gonen N, Zarhin D, Ruggiero A, Atsmon R, Gazit N, Braun G, Frere S, Vertkin I, Shapira I, Harel M, Heim LR, Katsenelson M, Rechnitz O, Fadila S, Derdikman D, Rubinstein M, Geiger T, Ruppin E, Slutsky I. Mitochondrial regulation of the hippocampal firing rate set point and seizure susceptibility. Neuron. 2019;102:1009–1024. doi: 10.1016/j.neuron.2019.03.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Sugino K, Hempel CM, Miller MN, Hattox AM, Shapiro P, Wu C, Huang ZJ, Nelson SB. Molecular taxonomy of major neuronal classes in the adult mouse forebrain. Nature Neuroscience. 2006;9:99–107. doi: 10.1038/nn1618. [DOI] [PubMed] [Google Scholar]
  57. Sun Q, Turrigiano GG. Psd-95 and PSD-93 play critical but distinct roles in synaptic scaling up and Down. The Journal of Neuroscience. 2011;31:6800–6808. doi: 10.1523/JNEUROSCI.5616-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Tan HL, Queenan BN, Huganir RL. Grip1 is required for homeostatic regulation of AMPAR trafficking. PNAS. 2015;112:10026–10031. doi: 10.1073/pnas.1512786112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Tatavarty V, Torrado Pacheco A, Groves Kuhnle C, Lin H, Koundinya P, Miska NJ, Hengen KB, Wagner FF, Van Hooser SD, Turrigiano GG. Autism-Associated Shank3 is essential for homeostatic compensation in rodent V1. Neuron. 2020;106:769–777. doi: 10.1016/j.neuron.2020.02.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Thiagarajan TC, Lindskog M, Tsien RW. Adaptation to synaptic inactivity in hippocampal neurons. Neuron. 2005;47:725–737. doi: 10.1016/j.neuron.2005.06.037. [DOI] [PubMed] [Google Scholar]
  61. Toyoizumi T, Abbott LF. Beyond the edge of chaos: amplification and temporal integration by recurrent networks in the chaotic regime. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 2011;84:051908. doi: 10.1103/PhysRevE.84.051908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, Nelson SB. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature. 1998;391:892–896. doi: 10.1038/36103. [DOI] [PubMed] [Google Scholar]
  63. Turrigiano GG, Nelson SB. Homeostatic plasticity in the developing nervous system. Nature Reviews. Neuroscience. 2004;5:97–107. doi: 10.1038/nrn1327. [DOI] [PubMed] [Google Scholar]
  64. Van Hooser S. Vhlab-twophoton-matlab. swh:1:rev:2357d2526a366471d0cbbabf25da6810144ebe7aSoftware Heritage. 2023 https://archive.softwareheritage.org/swh:1:dir:d82213dafb93706b01465b3aec384c8eaa899e9c;origin=https://github.com/VH-Lab/vhlab-TwoPhoton-matlab;visit=swh:1:snp:30164143f91ff828df0c0733ca24a89ca9ebe32d;anchor=swh:1:rev:2357d2526a366471d0cbbabf25da6810144ebe7a
  65. Vatine G, Vallone D, Appelbaum L, Mracek P, Ben-Moshe Z, Lahiri K, Gothilf Y, Foulkes NS. Light directs zebrafish period2 expression via conserved D and E boxes. PLOS Biology. 2009;7:e1000223. doi: 10.1371/journal.pbio.1000223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Wahlestedt M, Ladopoulos V, Hidalgo I, Sanchez Castillo M, Hannah R, Säwén P, Wan H, Dudenhöffer-Pfeifer M, Magnusson M, Norddahl GL, Göttgens B, Bryder D. Critical modulation of hematopoietic lineage fate by hepatic leukemia factor. Cell Reports. 2017;21:2251–2263. doi: 10.1016/j.celrep.2017.10.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Wallace W, Bear MF. A morphological correlate of synaptic scaling in visual cortex. The Journal of Neuroscience. 2004;24:6928–6938. doi: 10.1523/JNEUROSCI.1110-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Wang Q, Maillard M, Schibler U, Burnier M, Gachon F. Cardiac hypertrophy, low blood pressure, and low aldosterone levels in mice devoid of the three circadian PAR bzip transcription factors DBP, HLF, and tef. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2010;299:R1013–R1019. doi: 10.1152/ajpregu.00241.2010. [DOI] [PubMed] [Google Scholar]
  69. Wang Q, Chiu SL, Koropouli E, Hong I, Mitchell S, Easwaran TP, Hamilton NR, Gustina AS, Zhu Q, Ginty DD, Huganir RL, Kolodkin AL. Neuropilin-2/plexina3 receptors associate with GluA1 and mediate sema3f-dependent homeostatic scaling in cortical neurons. Neuron. 2017;96:1084–1098. doi: 10.1016/j.neuron.2017.10.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Weger BD, Gobet C, David FPA, Atger F, Martin E, Phillips NE, Charpagne A, Weger M, Naef F, Gachon F. Systematic analysis of differential rhythmic liver gene expression mediated by the circadian clock and feeding rhythms. PNAS. 2021;118:e2015803118. doi: 10.1073/pnas.2015803118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Wierenga CJ, Walsh MF, Turrigiano GG. Temporal regulation of the expression locus of homeostatic plasticity. Journal of Neurophysiology. 2006;96:2127–2133. doi: 10.1152/jn.00107.2006. [DOI] [PubMed] [Google Scholar]
  72. Wingender E, Schoeps T, Haubrock M, Dönitz J. TFClass: a classification of human transcription factors and their rodent orthologs. Nucleic Acids Research. 2015;43:D97–D102. doi: 10.1093/nar/gku1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Yoshimura T, Rasband MN. Axon initial segments: diverse and dynamic neuronal compartments. Current Opinion in Neurobiology. 2014;27:96–102. doi: 10.1016/j.conb.2014.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]

Editor's evaluation

Yukiko Goda 1

Homeostatic plasticity helps to maintain the stability of neural network activity. This study shows that activation of PAR bZIP family of transcription factors restrains homeostatic upregulation of network activity in response to activity deprivation in mouse brain slice cultures. The identification of an endogenous transcriptional program that limits upward homeostatic response and helps prevent aberrant activity associated with epilepsy and brain disorders is important, and the findings will be of interest to a broad neuroscience community.

Decision letter

Editor: Yukiko Goda1
Reviewed by: Yukiko Goda2

Our editorial process produces two outputs: (i) public reviews designed to be posted alongside the preprint for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.

Decision letter after peer review:

Thank you for submitting your article "A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, including Yukiko Goda as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Gary Westbrook as the Senior Editor.

The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.

Essential revisions:

All three reviewers acknowledge that the study provides novel insights into a long-standing question about the mechanisms that constrain homeostatic synaptic plasticity, and the findings are exciting and of broad interest. However, a couple of major concerns have been raised regarding (a) the interpretation of calcium imaging data and (b) data quantification, effect sizes and statistics in a number of experiments.

(a) The main conclusion that PAR bZIP transcription factors constrain the network activity via regulating excitatory synapses should be further strengthened by addressing the following two points:

(i) Ruling out the contribution of changes in inhibitory synaptic transmission in TKO neurons. If the authors cannot rule out the contribution, then calcium imaging experiments should be conducted also in excitatory or inhibitory neurons to clarify the relative contributions.

(ii) In addition, calcium imaging, as the key physiology data, should be performed in WT and TKO cultures for two time points: after 2 days in TTX and after 5 days in TTX. Monitoring the kinetics will help in better relating the physiology data to the RNA-seq data and to clarify whether TKO cultures overshoots or if they show a faster compensation.

(b) The authors should fully address the concerns regarding data quantification and statistics that are raised by Reviewers 2 and 3.

Reviewer #1 (Recommendations for the authors):

1. The initial RNA seq analysis in Figure 1A,B compares control vs. TTX in L5-6 pyramidal and PV+ neurons. How well does the observation of strong upregulation of HFL and TEF extend to pyramidal and PV+ cells for a 2-day TTX treatment that is used for much of the later experiments? Notably, calcium imaging based on synapsin promoter-driven GCaMP6f expression does not specify cortical layers being targeted nor discriminate between excitatory and inhibitory neurons.

2. Figure 2. It would be informative to monitor calcium dynamics in a cell-type specific manner to decipher the differences in homeostatic response between WT and mutant neurons.

3. Line 266-269. It seems premature to conclude that homeostatic plasticity of mIPSCs is not driving the TTX-dependent change in network activity based on the fact that the levels of mIPSC amplitude and frequency are indistinguishable between WT and mutant after TTX treatment. In particular, the striking reduction in mIPSC amplitude in the baseline in the mutant prep indicates that already some form of compensation for altered mIPSCs has taken place to keep the network activity level comparable between WT and mutant prior to TTX treatment. In addition, the observed lack of a further change in mIPSCs could be due to saturation of mIPSC-dependent mechanisms.

Reviewer #2 (Recommendations for the authors):

I have concerns, mainly revolving around statistics and effect sizes:

1. Based on the RNA seq data shown in figure 1, it is unclear why the authors focused their analyses on Hlf, Tef and Dbp, because the data suggest more pronounced regulation of other genes. The authors should explain why these candidates were chosen for further analysis in the Results section.

2. One of the central findings of this study is that Hlf-/-/Dbp-/-/Tef-/- triple knockout (TKO) slice cultures display a more pronounced increase in calcium peak frequency upon TTX treatment compared to WT controls. In the Results section, it is mentioned that TTX treatment induces a two-fold increase in calcium peak frequency in WT, and a four-fold increase in TKO cultures (l. 142, 143). However, based on the mean data plotted in figure 2D, the increase in WT is around 3-4-fold (15 peaks x s^-1/4 peaks x s^-1=3.5), whereas the one in TKO is around four-fold (30/7.5=4). Could the authors comment on the discrepancy between the text and the data? Furthermore, it is key to test for an interaction between treatment and genotype to support this major conclusion by statistics. Additionally, it would be helpful to plot the relative increase in calcium peak frequency upon TTX treatment in WT and TKO.

3. On a similar note, although not statistically significant, the mean calcium peak frequency in TKO cultures is around two-fold higher than WT under baseline conditions (Figure 2D). A similar trend can be seen in the data shown in figure 6A (top panel), whereas the baseline calcium peak frequency is similar between TKO and controls in the experiment shown in Figure 2B. Based on the scatter of the data, can the authors exclude that baseline calcium peak frequency is increased in TKO cultures? I suggest running a power analysis for these data to verify if the sample sizes are sufficient to support their conclusions. Otherwise, sample sizes would have to be increased, or the conclusions should be revised/toned down. Alternatively, could additional parameters, such as inter-burst interval, be read out to support the conclusions that baseline network excitability is unchanged in TKO cultures, and that TTX application leads to a more pronounced increase in calcium peak frequency? Another possibility may be to pool the data of the different experiments?

4. Based on the data shown in figure 6, they conclude that one copy of Tef is sufficient to constrain homeostatic plasticity. Can they rule out that one copy of Hlf is sufficient as well? This would actually fit to the result that one copy of Tef or Hlf rescues lifespan in TKO. The peak frequencies of DKO;Tef +/- and DKO;Hlf +/- after TTX treatment actually look quite similar. Are these two groups statistically different from one another? Only comparing the absolute DKO;Tef +/- or DKO;Hlf +/- data to WT is not very informative. Again, I suggest normalizing the data of each genotype to the respective control, and to test for interactions between treatment and genotype.

5. Sample sizes (culture number/ if applicable, neuron number) should be clearly specified for each experiment. Are some data sets only based on two cultures (e.g. Figure 6 ctrl.)? Again, a power analysis may be helpful to determine sample sizes.

6. The major (recorded) effect underlying the increase in network excitability is an increase in mEPSC frequency. Does this indicate that the mechanisms that constrain homeostatic plasticity mainly work on presynaptic mechanisms, or an increase in synapse number? These possibilities should be also discussed.

7. TTX application increases mEPSC frequency by around two-fold and does not affect other recorded parameters, such as excitability. How could a two-fold increase in mEPSC frequency translate into a four-fold increase in calcium peak frequency? Is there any evidence for a supralinear increase in network activity with regard to miniature frequency? This issue should be discussed.

8. What is the evidence for 'exaggerated' homeostatic plasticity in TKO cultures? Can they rule out that TKO neurons compensate better? This possibility should be discussed unless they can exclude the possibility that TKO cultures indeed do not retarget set-point activity.

Other comments:

1. It would be very helpful if the abstract could contain more specific information (e.g. experimental system, what kind of homeostatic plasticity was studied, some specific results etc.)

2. The more pronounced increase in mEPSC frequency upon TTX treatment in TKO cultures compared to WT (Figure 3B) appears more robust than the corresponding changes in calcium peak frequency (Figure 2). However, they should also test for an interaction between treatment and genotype to support their conclusion by statistics for the data shown in figure 3B, C.

3. Similarly, although not statistically significant, the decrease in mIPSC frequency upon TTX treatment seems less pronounced in TKO cultures (Figure 4B, C). Could they run a power analysis and test for treatment-group interaction as well?

4. mIPSC amplitudes are decreased in TKO cultures, and there is no further decrease upon TTX application (Figure 4D, E). First, the decrease in baseline mIPSC amplitude in TKO is interesting, and may represent a homeostatic response that counteracts a potential increase in excitability/ calcium peak frequency under baseline conditions (Figure 2D, major point 3). This possibility should be discussed in addition to previous work indicating reduced glutamate decarboxylase function in PLP KOs. Second, could the lack of a decrease in mIPSC amplitude after TTX in TKO neurons also oppose increased network excitability? This possibility should be also discussed.

5. TTX treatment results in a rapid regulation of Hlf and Tef mRNA on the hour time scale (Figure 1C). The mEPSC/IPSC recordings were carried out in the presence of TTX. It is thus crucial to mention the time window during which WT recordings were conducted with regard to the beginning of TTX incubation to assess whether Hlf or Tef transcripts could be increased in the control group.

6. I suggest using the SI unit Hz instead of peaks/minute for the calcium imaging data.

7. The figure labels "mutant" could be more specific (e.g., Hlf,Dbp,Tef TKO).

8. Some figures are not referenced in the text.

9. It should be briefly described how miniature PSCs and APs were analyzed (e.g. template matching, threshold, or the likes…).

Reviewer #3 (Recommendations for the authors):

I have a few suggestions for the authors that may strengthen the manuscript:

1. Quantification of the network activity homeostasis (Figure 2 and its supplemental figure): The authors provided quantification of frequency of Ca events (probably associated with spike bursts). It is unclear why the amplitude was not taken into account. Mean firing rate should be better reflected by frequency x amplitude calculation.

2. What is the mechanism that links spike silencing to activation of PAR-bZIP TFs by inactivity? Is it mediated by the previously described mechanisms related to T-type Ca channels (Schaukowitch et al. Cell Reports 2017) or L-type Ca channels and CaMK4 (Li et al. Cell 2020)? This should be at least discussed.

3. I am not sure I agree with the interpretation of mIPSC results. The results show that both frequency and amplitude homeostatic down-regulation are disabled by TF deletion. This, in my view, may be a possible compensation to prevent a further increase in the E/I ratio (meaning that without it epilepsy would be even more severe).

Statistics: I could not find cell numbers (n) in the legends / text for each experiment.

line 179 – did the authors mean removal of silencing?

eLife. 2023 Feb 7;12:e74899. doi: 10.7554/eLife.74899.sa2

Author response


Essential revisions:

All three reviewers acknowledge that the study provides novel insights into a long-standing question about the mechanisms that constrain homeostatic synaptic plasticity, and the findings are exciting and of broad interest. However, a couple of major concerns have been raised regarding (a) the interpretation of calcium imaging data and (b) data quantification, effect sizes and statistics in a number of experiments.

Please see detailed replies below.

(a) The main conclusion that PAR bZIP transcription factors constrain the network activity via regulating excitatory synapses should be further strengthened by addressing the following two points:

(i) Ruling out the contribution of changes in inhibitory synaptic transmission in TKO neurons. If the authors cannot rule out the contribution, then calcium imaging experiments should be conducted also in excitatory or inhibitory neurons to clarify the relative contributions.

Previously we did some pilot experiments trying to attribute individual cellular firing to pyramids or subtypes of interneurons. We do not think this will be informative in the TTX condition (in either genotype) because the network activity is so intense and is shared across almost all cells in the network. Both interneurons and pyramids receive both excitation and inhibition, but the recurrent excitation is so powerful that all cells fire near simultaneously. Hence we do not believe we can clarify their relative contributions in this way. Therefore, we think that the more difficult experiment of manipulating HLF and TEF independently in pyramids and interneurons, and/or sparsely in individual cells will be much more informative, but this will take significant additional work.

(ii) In addition, calcium imaging, as the key physiology data, should be performed in WT and TKO cultures for two time points: after 2 days in TTX and after 5 days in TTX. Monitoring the kinetics will help in better relating the physiology data to the RNA-seq data and to clarify whether TKO cultures overshoots or if they show a faster compensation.

We performed additional experiments after 5 days in TTX as well as additional experiments to expand the sample size at 2 days in TTX. We report the data in Figure 2—Figure Supplement 1C-D. Response to TTX in 5 day-treated cultures is comparable to that at 2 days in TTX and the TKO phenotype is similar with the longer TTX incubation.

(b) The authors should fully address the concerns regarding data quantification and statistics that are raised by Reviewers 2 and 3.

We address these concerns and other concerns raised by each reviewer below.

Reviewer #1 (Recommendations for the authors):

1. The initial RNA seq analysis in Figure 1A,B compares control vs. TTX in L5-6 pyramidal and PV+ neurons. How well does the observation of strong upregulation of HFL and TEF extend to pyramidal and PV+ cells for a 2-day TTX treatment that is used for much of the later experiments? Notably, calcium imaging based on synapsin promoter-driven GCaMP6f expression does not specify cortical layers being targeted nor discriminate between excitatory and inhibitory neurons.

Data showing upregulation of Hlf and Tef at multiple time points following initiation of TTX treatment is shown in Figure 1C. Real-time PCR experiments from RNA extracted from whole cortical slice cultures were performed at 4 hours, 1 day, 3 days and 5 days. Due to the small number of replicates, the data were underpowered for full posthoc testing of all genes/time points. However, t-tests revealed significant upregulation of both Hlf and Tef relative to Rpl10 after 24 hours in TTX (p = 0.018, 0.012).

2. Figure 2. It would be informative to monitor calcium dynamics in a cell-type specific manner to decipher the differences in homeostatic response between WT and mutant neurons.

We chose not to monitor calcium dynamics in a cell-type specific manner because, following TTX treatment, the activity of nearly all neurons in the slice are highly correlated in both genotypes (synchrony near 0.95) and are driven by strong recurrent connectivity. Hence, we do not believe there would be informative differences. We do believe that selectively manipulating Hlf and Tef in excitatory vs. inhibitory neurons would be instructive, but unfortunately the knockout available to us is a germline deletion. We plan to address this issue with additional experiments in the future, but this is likely to require very significant additional work and so is outside of the scope of this study.

3. Line 266-269. It seems premature to conclude that homeostatic plasticity of mIPSCs is not driving the TTX-dependent change in network activity based on the fact that the levels of mIPSC amplitude and frequency are indistinguishable between WT and mutant after TTX treatment. In particular, the striking reduction in mIPSC amplitude in the baseline in the mutant prep indicates that already some form of compensation for altered mIPSCs has taken place to keep the network activity level comparable between WT and mutant prior to TTX treatment. In addition, the observed lack of a further change in mIPSCs could be due to saturation of mIPSC-dependent mechanisms.

We acknowledge that the reviewer is correct and emended our statement:

“Thus, both the amplitude and frequency of mIPSCs received by pyramidal neurons after activity deprivation are indistinguishable from the wild-type in the TKO slices, suggesting that homeostatic plasticity of mIPSCs is not directly driving the changes in the network activity following TTX treatment. We cannot rule out the possibility that although baseline activity is normal, the baseline reduction in mIPSC amplitude contributes to subsequent network plasticity indirectly by contributing to induction of the changes in EPSCs observed, or by inducing some form of compensation other than the physiological parameters measured.”

Reviewer #2 (Recommendations for the authors):

I have concerns, mainly revolving around statistics and effect sizes:

1. Based on the RNA seq data shown in figure 1, it is unclear why the authors focused their analyses on Hlf, Tef and Dbp, because the data suggest more pronounced regulation of other genes. The authors should explain why these candidates were chosen for further analysis in the Results section.

We added additional explanation to this section of the paper as follows:

“To identify potential transcriptional regulators of homeostatic plasticity, we looked for transcription factors (TFs) upregulated in the TTX condition. TFs can be classified into families, and in some cases subfamilies, which share a DNA binding domain, and so are expected to bind the same target DNA sequences in the genome and therefore to regulate the same or similar target transcripts. We asked which families or subfamilies were most over-represented amongst the TFs differentially expressed during activity blockade. The most overrepresented subfamily was the PAR bZIP subfamily of TFs, a subtype of the CEBP-related family in the class of Basic leucine zipper factors (classification data from tfclass.bioinf.med.uni-goettingen.de Wingender et al. 2015 ). This subfamily includes 3 transcriptional activators Hlf, Tef, and Dbp, and a transcriptional repressor, Nfil3.”

2. One of the central findings of this study is that Hlf-/-/Dbp-/-/Tef-/- triple knockout (TKO) slice cultures display a more pronounced increase in calcium peak frequency upon TTX treatment compared to WT controls. In the Results section, it is mentioned that TTX treatment induces a two-fold increase in calcium peak frequency in WT, and a four-fold increase in TKO cultures (l. 142, 143). However, based on the mean data plotted in figure 2D, the increase in WT is around 3-4-fold (15 peaks x s^-1/4 peaks x s^-1=3.5), whereas the one in TKO is around four-fold (30/7.5=4). Could the authors comment on the discrepancy between the text and the data? Furthermore, it is key to test for an interaction between treatment and genotype to support this major conclusion by statistics. Additionally, it would be helpful to plot the relative increase in calcium peak frequency upon TTX treatment in WT and TKO.

We thank the reviewer for catching the discrepancy. We performed additional experiments and have re-analyzed the old and new data together. We have fixed the text to reflect the data and have plotted the peak frequency normalized to control (Supplemental Figure 2A) as well as non-normalized frequency in Hz. The combined data and analysis further strengthen our conclusion that there is no change in network activity level at baseline between WT and TKO cultures.

We tested for interactions and found highly significant (<0.0001) interaction between treatment and genotype. We include the results in the text (line 141).

“While 2 days of TTX incubation increases the peak frequency 3.6-fold in WT slices (from 0.06 +/- 0.01 to 0.22 +/- 0.04 Hz), the same silencing duration produces a nearly six-fold increase in the TKO slices (from 0.09 +/- 0.02 Hz to 0.5 +/- 0.05 Hz; Figure 2, Figure 2—Figure Supplement 1A). A two-way ANOVA revealed significant effects of treatment (TTX vs. Control; p<0.0001) and genotype (p<0.0001) and a significant interaction between the two (p<0.0001). Post hoc T-tests (with Tukey correction for multiple comparisons) revealed that TTX increases in activity were highly significant in both WT (p = 0.0007) and TKO (p<0.0001) slices and that TTX produced a significantly stronger increase in the TKO (p<0.0001), while the baseline activity of cells from slices derived from the TKO and WT do not differ significantly (p=0.92). Consistent with this, normalizing the TTX response to the control response revealed a larger relative increase in TKO than WT cultures (Figure 2—Figure supplement 1A).”

3. On a similar note, although not statistically significant, the mean calcium peak frequency in TKO cultures is around two-fold higher than WT under baseline conditions (Figure 2D). A similar trend can be seen in the data shown in figure 6A (top panel), whereas the baseline calcium peak frequency is similar between TKO and controls in the experiment shown in Figure 2B. Based on the scatter of the data, can the authors exclude that baseline calcium peak frequency is increased in TKO cultures? I suggest running a power analysis for these data to verify if the sample sizes are sufficient to support their conclusions. Otherwise, sample sizes would have to be increased, or the conclusions should be revised/toned down. Alternatively, could additional parameters, such as inter-burst interval, be read out to support the conclusions that baseline network excitability is unchanged in TKO cultures, and that TTX application leads to a more pronounced increase in calcium peak frequency? Another possibility may be to pool the data of the different experiments?

We performed additional experiments, reanalyzed our existing data and replotted the figures including the additional experiments. A small subset of experiments were excluded because the calcium signal was too low to accurately measure changes in firing. We have made the exclusion criteria clear in the methods. The previous trend towards an increase at baseline is no longer present with the additional data (Figure 2D). Additionally, we now report synchrony, a measure of the average cross-correlation at zero lag during network bursts (figure 2 supplement 1B). The synchrony metric saturates in the WT TTX condition, making it unsuitable for detecting further increases in network activity and so we use peak frequency for most of the rest of the manuscript. We also performed a power analysis. The synchrony results and power analysis are described in the following sentences (line 152):

“The TTX condition also increased synchrony (from 0.76 +/- 0.03 to 0.95 +/- 0.01) in WT, and in the TKO (from 0.74 +/- 0.03 to 0.94 +/- 0.05; Figure 2—Figure Supplement 1B). While the TTX effects were highly significant (Two-way ANOVA; p<0.0001), there was no significant effect of genotype (p=0.43) and no interaction between treatment and genotype (p=0.65), presumably reflecting the fact that synchrony is already saturated by TTX treatment in the WT and cannot further increase in the TKO, but also indicating that baseline synchrony is not altered in the TKO. A power test revealed that with the effect size and variances observed, 95 slice cultures in each group would be needed to detect a significant difference between WT and TKO peak frequency, while for the synchrony measure, the required N would be 1609.”

4. Based on the data shown in figure 6, they conclude that one copy of Tef is sufficient to constrain homeostatic plasticity. Can they rule out that one copy of Hlf is sufficient as well? This would actually fit to the result that one copy of Tef or Hlf rescues lifespan in TKO. The peak frequencies of DKO;Tef +/- and DKO;Hlf +/- after TTX treatment actually look quite similar. Are these two groups statistically different from one another? Only comparing the absolute DKO;Tef +/- or DKO;Hlf +/- data to WT is not very informative. Again, I suggest normalizing the data of each genotype to the respective control, and to test for interactions between treatment and genotype.

We agree with the reviewer’s skepticism of our ability to distinguish the contributions of Hlf and Tef and wrestled with how best to perform this analysis. A key limitation is that there are 27 potential genotypes (Null, Het, wild type) for the three genes considered jointly and so even with a total of 185 experiments (87 Control and 98 TTX) we were almost definitely underpowered for most specific comparisons. Rather than attempt to make all possible pairwise comparisons, we chose to put all of the data together (the 88 experiments shown in figure 2 and figure 2—figure supplement 1, as well as 97 additional experiments that included those shown in the earlier version of figure 6 as well as some additional experiments we performed in the past year). We then fit these data with a series of linear regression models to determine the relationship between peak frequency and genotype. The same set of six models were used to separately fit the data from control slices and from TTX-treated slices.

These analyses are described in the following section (line 258):

“To test whether Hlf, Tef, and Dbp work together to regulate homeostatic plasticity or if they have unequal contributions to restraining network response to activity deprivation, we measured the homeostatic response while varying gene copy number of each transcription factor. In addition to the WT and TKO data described in Figure 2 and Figure 2—Figure Supplement 1, we measured calcium transients in slice cultures treated with or without TTX from 97 additional animals with various combinations of 0, 1 or 2 alleles of Hlf, Tef and Dbp (full details of each experiment given in associated data file). Rather than attempt to statistically test individual differences between each of 27 potential genotypes (Null, Het, wild type for the three genes considered jointly), we fit a series of multivariate linear models to test the ability of genotype to predict calcium peak frequency. The same six models, described in Table 1, were fit separately to data from control and TTX-treated slices. The models, shown in Table 1, differ in how they depend on the number of alleles of each of the three genes. Model 1 depends on all three genes, models 2-4 depend only on one of the three genes (each in turn) and models 5 and 6 depend only on Hlf and Tef, either independently, or summed together. The ability of each model to account for the data was estimated from the adjusted R2 which reflects the fraction of the variance in the data predicted by the model variables. Several key points were evident from this analysis:

1) All of the models produced poor fits (adjusted R2 of -0.01 to 0.063) to the control data, consistent with the hypothesis that baseline activity does not depend on genotype.

2) All of the models that included variables for Hlf and/or Tef produced much better fits to the TTX data (adjusted R2 of 0.198 to 0.296) consistent with the hypothesis that rebound activity is influenced by genotype. In these models, the coefficients (effect size) for Hlf and Tef were similar and T-tests revealed they were highly significantly different from zero.

3) The model that only depended on Dbp (line 4) provided a poor fit to the TTX data (adjusted R2 = 0.073) and in the model that included both terms for Dbp and the other two factors (line 1), the Dbp coefficient was small and not significantly different from zero. These observations are consistent with the hypothesis that rebound activity does not depend on Dbp and that even in a significant model including Hlf and Tef, Dbp does not add additional explanatory power to the model.

3) The models that included terms for both Hlf and Tef (line 5) or for their sum (line 6) produced the best fits (adjusted R2 = 0.291 and 0.296); i.e. better than those that depend on only one of these factors (lines 2,3; adjusted R2 = 0.198, 0.229). This is consistent with the hypothesis that both genes contribute to constraining cortical homeostatic plasticity.

Since the model with the highest adjusted R2 was that which depended only on the sum of the number of Hlf and Tef alleles (line 6), we used this model for further post hoc (Tukey) tests to determine the effect of different numbers of alleles on the TTX response. The results of this analysis are shown in Figure 6. The most significant differences were between TKO slices (0 alleles; n=32, mean=0.48) and the other genotypes tested (1 allele, n=16, mean=0.32; 2 alleles, n=26, mean=0.35; and 4 alleles, n=24, mean=0.23; p <0.0001 to 0.0014). Most of the other comparisons were not significant, with the exception of the difference between WT responses and those for animals with only two alleles (p=0.011). This indicates that most of the difference between TKO (zero alleles of Hlf + Tef) and WT (4 alleles of Hlf + Tef) could be restored by a single allele, although there was a small but significant improvement between 2 and 4 alleles. The fact that this difference was significant, but the differences between 1 and 2 alleles, and 1 and 4 alleles were not, may reflect a real difference between these groups, or may reflect the imbalanced numbers of animals in each group. The group with 2 alleles included animals that were WT for Hlf but lacked Tef (N=8), animals that were WT for Tef and lacked Hlf (N=9), and trans-Het animals that were heterozygous for both Hlf and Tef (N=7). A separate analysis of variance of these three subgroups revealed that the means (0.32, 0.41 and 0.33) were not significantly different (p=0.28), consistent with the hypothesis that alleles of Hlf and Tef can substitute for one another in their ability to regulate the homeostatic response to activity deprivation.”

5. Sample sizes (culture number/ if applicable, neuron number) should be clearly specified for each experiment. Are some data sets only based on two cultures (e.g. Figure 6 ctrl.)? Again, a power analysis may be helpful to determine sample sizes.

We performed additional experiments and added additional data to figure 6. The N’s for each major group are stated in the legend (#cultures) and the precise genotypes for every experiment and the # neurons selected in each slice are provided in the accompanying supporting data file. We did not perform a power analysis for each model.

6. The major (recorded) effect underlying the increase in network excitability is an increase in mEPSC frequency. Does this indicate that the mechanisms that constrain homeostatic plasticity mainly work on presynaptic mechanisms, or an increase in synapse number? These possibilities should be also discussed.

We add a discussion of potential mechanism underlying this change to the Discussion section of the manuscript:

“Although two days of activity blockade in dissociated cortical cultures were initially found to produce scaling up of EPSC amplitudes without accompanying changes in mEPSC frequency (Turrigiano et al., 1998), multiple subsequent studies have found evidence for changes in both amplitude and frequency as found here (Wierenga et al., 2006; Koch et al., 2010; Echegoyan et al., 2007; Thiagarajan et al., 2005). Changes in mini frequency are typically interpreted as reflecting increased presynaptic release, either via increases in the numbers of synapses or active release sites, or via changes in the rate at which spontaneous, action potential independent release occurs at each site.”

7. TTX application increases mEPSC frequency by around two-fold and does not affect other recorded parameters, such as excitability. How could a two-fold increase in mEPSC frequency translate into a four-fold increase in calcium peak frequency? Is there any evidence for a supralinear increase in network activity with regard to miniature frequency? This issue should be discussed.

With inclusion of additional data, the increase in mEPSC frequency following TTX was 1.7-fold larger in the TKO than in WT (Figure 3B, while the change in network activity measured from calcium peak frequency was 1.6-fold greater Figure 2D) at 2 days and 2.5-fold greater at 5 days. We added discussion of the relationship in the following paragraph:

“Although the increase observed in mEPSC frequency (1.7-fold greater in TKO than WT), was lower than the relative increase in activity levels, measured from the frequency of calcium transients (2.5-fold greater in TKO than WT at 5 days), these two measures need not be linearly related. First, mini frequency can be distinct from action potential evoked release (Crawford et al., 2017) and second, in a highly recurrent network, the relationship between firing and synaptic strength can be nonlinear (Toyoizumi and Abbott, 2011).”

8. What is the evidence for 'exaggerated' homeostatic plasticity in TKO cultures? Can they rule out that TKO neurons compensate better? This possibility should be discussed unless they can exclude the possibility that TKO cultures indeed do not retarget set-point activity.

Although we are not positive we understand the point the reviewer is making, we think he/she is suggesting that we do not know whether the genetic manipulation changes rebound activity following activity deprivation because of a change in the vigor or speed with which the network attempts to restore activity (which we refer to as exaggerated homeostatic plasticity) or a change in the set point to which activity is trying to return, or both.

We directly tested this possibility in the experiment shown in figure 2 supplement 2. We observe that in the TKO, rebound activity is indeed higher, but it returns to the same baseline level after two days of recovery in normal media lacking TTX. We realize that we did not adequately highlight the significance of this result and thank the reviewer for spurring us to make this clearer. We added the following sentences to the Results section of the manuscript (line 174):

“In addition, changes in activity following rebound from deprivation could reflect either a change in the vigor of the circuit’s attempt to restore activity (i.e. enhanced homeostatic plasticity) or a persistent change in the setpoint to which activity is returned (Styr et al., 2019), or both. To test whether the transcriptional restraint of homeostasis is required for bidirectional flexibility and to assess whether the setpoint had changed, we asked whether the network is able to return back to baseline activity levels when the activity blockade is removed. We measured network activity immediately after the end of silencing with TTX as well as following two days of recovery in TTX-free media. In WT slices, activity deprivation causes hyperactivity, evident from a two-fold rise in the peak frequency of the calcium activity. However, this exuberant activity is restored back to baseline levels within two days following restoration of action potential firing. In the mutant, even though the initial response to TTX is exaggerated, the network is also able to return to baseline levels following two days of recovery, to levels indistinguishable from WT (Figure 2—Figure Supplement 2). These data suggest that the recovery from a high activity state is not diminished in the TKO and suggests that the mutation in fact produces exaggerated homeostatic plasticity rather than a change in activity setpoint.”

Other comments:

1. It would be very helpful if the abstract could contain more specific information (e.g. experimental system, what kind of homeostatic plasticity was studied, some specific results etc.)

We have reworked the abstract to be more descriptive and to include these details.

2. The more pronounced increase in mEPSC frequency upon TTX treatment in TKO cultures compared to WT (Figure 3B) appears more robust than the corresponding changes in calcium peak frequency (Figure 2). However, they should also test for an interaction between treatment and genotype to support their conclusion by statistics for the data shown in figure 3B, C.

We now include these statistical analyses including the interaction between treatment and genotype in the figure legend.

3. Similarly, although not statistically significant, the decrease in mIPSC frequency upon TTX treatment seems less pronounced in TKO cultures (Figure 4B, C). Could they run a power analysis and test for treatment-group interaction as well?

We now test for interactions between the treatment and the genotype and report the findings in the figure legend along with a power analysis of the sample size that would be required for the observed difference to be significant:

“Two-way ANOVA revealed a significant main effect of TTX treatment (p<0.0001) but not genotype (p=0.54). There was no significant interaction between treatment and genotype (p=0.40), N=28 for WT control, N=37 for WT TTX, N=23 for TKO control, N=20 for TKO TTX. TTX treatment decreased mIPSC frequency in WT (p=0.0007, post hoc Tukey test) but not in TKO cells (p=0.14, post hoc Tukey test). mIPSC frequency in TTX-treated cells is not different in TKO slices compared to WT (p=0.72). The normalized change in frequency (TTX normalized to Control) was 0.55 in WT and 0.70 in TKO. We performed a power analysis that revealed that for the observed effect size and variance a sample of 68 neurons per condition would be required for significance.”

4. mIPSC amplitudes are decreased in TKO cultures, and there is no further decrease upon TTX application (Figure 4D, E). First, the decrease in baseline mIPSC amplitude in TKO is interesting, and may represent a homeostatic response that counteracts a potential increase in excitability/ calcium peak frequency under baseline conditions (Figure 2D, major point 3). This possibility should be discussed in addition to previous work indicating reduced glutamate decarboxylase function in PLP KOs. Second, could the lack of a decrease in mIPSC amplitude after TTX in TKO neurons also oppose increased network excitability? This possibility should be also discussed.

The decrease in mIPSC amplitude observed would not be expected to represent a homeostatic response counteracting increased excitability/ calcium peak frequency since it would exacerbate the resulting increase in network excitability. Furthermore, as noted above, additional experiments make it clearer that baseline frequency is not altered. The prior work on reduced glutamate decarboxylase function is discussed in the following paragraph:

Gachon et al. (Gachon et al., 2004) first reported that deletion of the PARbZIP proteins TEF, HLF and DBP caused spontaneous and audiogenic seizures. They suggested that this may reflect effects on neurotransmitter metabolism caused by a reduction in pyridoxal phosphate (PLP) since pyridoxal kinase, which catalyzes the last step in the conversion of vitamin B6 into PLP is a target of the PAR bZIP proteins. PLP is a required cofactor for decarboxylases and other enzymes involved in the synthesis and metabolism of GABA, glutamate and the biogenic amine neurotransmitters including dopamine, serotonin and histamine. Using HPLC they found no changes in GABA or glutamate, but reduced levels of dopamine, serotonin and histamine in the knockout animals. Although changes in amine transmitters could potentially contribute to phenotypes in vivo, they are unlikely to contribute to plasticity in cortical slice cultures which do not include the brainstem nuclei from which these projections arise. Reduced glutamate decarboxylase action could potentially have contributed to the observed baseline reduction in mIPSCs since heterozygous (Lazarus et al., 2015) and homozygous (Lau and Murthy, 2012) mutants of Gad1, the gene encoding the GAD67 isoform of glutamic acid decarboxylase, have reduced mIPSC amplitudes. However, this does not account for the enhanced homeostatic overshoot following activity blockade, since in the TKO animals, activity blockade did not produce any further reduction in inhibition but produced robust changes at excitatory synapses.”

5. TTX treatment results in a rapid regulation of Hlf and Tef mRNA on the hour time scale (Figure 1C). The mEPSC/IPSC recordings were carried out in the presence of TTX. It is thus crucial to mention the time window during which WT recordings were conducted with regard to the beginning of TTX incubation to assess whether Hlf or Tef transcripts could be increased in the control group.

We added the following detail to the methods section of the manuscript.

“The slices were incubated in TTX only during active recording, which lasted no more than 30 minutes for each slice.”

6. I suggest using the SI unit Hz instead of peaks/minute for the calcium imaging data.

We re-plotted all of our data in Hz.

7. The figure labels "mutant" could be more specific (e.g., Hlf,Dbp,Tef TKO).

We relabeled our figures as suggested.

8. Some figures are not referenced in the text.

We have now included reference to all the figures in the text.

9. It should be briefly described how miniature PSCs and APs were analyzed (e.g. template matching, threshold, or the likes…).

We added the following description to the methods:

“Threshold-based detection of mPSCs and action potentials were implemented using custom-written IGOR scripts equipped with routines for baseline subtraction, custom filtering and measurements of intervals, amplitudes and kinetic properties.”

Reviewer #3 (Recommendations for the authors):

I have a few suggestions for the authors that may strengthen the manuscript:

1. Quantification of the network activity homeostasis (Figure 2 and its supplemental figure): The authors provided quantification of frequency of Ca events (probably associated with spike bursts). It is unclear why the amplitude was not taken into account. Mean firing rate should be better reflected by frequency x amplitude calculation.

Although in principle the amplitude of calcium transients may provide additional information about the magnitude of the firing underlying these events, we found that the distribution of event amplitudes were dependent upon other experimental factors such as the amount of calcium indicator expressed as well as optical factors such as the depth of the cell in the slice. Although it may be possible with further calibration experiments to control for some of these factors, we decided instead to simply use the calcium transients as indicative of periods of neuronal firing without attempting to ascertain the precise number of action potentials contributing. We added the following summary of this idea to the methods:

“Since the distribution of event amplitudes across cells was potentially dependent on other experimental factors such as the amount of calcium indicator expressed as well as optical factors such as the depth of the cell in the slice, we decided not to try to infer the magnitude of firing from the amplitude of events, but only periods of elevated firing from the timing of events.”

2. What is the mechanism that links spike silencing to activation of PAR-bZIP TFs by inactivity? Is it mediated by the previously described mechanisms related to T-type Ca channels (Schaukowitch et al. Cell Reports 2017) or L-type Ca channels and CaMK4 (Li et al. Cell 2020)? This should be at least discussed.

We added the following speculative paragraph to the discussion:

“The mechanisms linking activity deprivation to Tef and Hlf activation were not directly addressed in this work, but seem likely to depend on reduced calcium influx. Prior studies have suggested alternately that scaling up of mEPSC amplitudes depends upon calcium influx through either T-type (Schaukowitch et al., 2017) or L-type (Li et al., 2020) calcium channels. The former pathway has also been found to depend on the activity-dependent transcription factors Elk1 and SRF. Activation of the constraining TFs Tef and Hlf could be secondary or delayed responses dependent on changes in the transcription and translation of other activity-dependent TFs, or may represent a primary response to activity deprivation, analogous to, but in the opposite direction of the well-studied immediate early genes such as Fos, Arc and others.”

3. I am not sure I agree with the interpretation of mIPSC results. The results show that both frequency and amplitude homeostatic down-regulation are disabled by TF deletion. This, in my view, may be a possible compensation to prevent a further increase in the E/I ratio (meaning that without it epilepsy would be even more severe).

We agree that we can’t exclude this possibility and add the following statement to the discussion:

“We cannot rule out the possibility that although baseline activity is normal, the baseline reduction in mIPSC amplitude contributes to subsequent network plasticity indirectly by contributing to induction of the changes in EPSCs observed, or by inducing some form of compensation other than the physiological parameters measured”

Statistics: I could not find cell numbers (n) in the legends / text for each experiment.

We thank the reviewer for catching the error and now report N values for each experiment.

line 179 – did the authors mean removal of silencing?

We have corrected the wording and thank the reviewer for pointing it out. The statement now reads:

“We measured network activity immediately after the end of silencing with TTX”ab

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104764 [DOI] [PMC free article] [PubMed]
    2. Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104765 [DOI] [PMC free article] [PubMed]
    3. Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104766 [DOI] [PMC free article] [PubMed]
    4. Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104767 [DOI] [PMC free article] [PubMed]
    5. Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104768 [DOI] [PMC free article] [PubMed]
    6. Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104769 [DOI] [PMC free article] [PubMed]
    7. Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104770 [DOI] [PMC free article] [PubMed]
    8. Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104771 [DOI] [PMC free article] [PubMed]
    9. Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104772 [DOI] [PMC free article] [PubMed]
    10. Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104773 [DOI] [PMC free article] [PubMed]
    11. Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104774 [DOI] [PMC free article] [PubMed]
    12. Nelson S, Velakh S, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104775 [DOI] [PMC free article] [PubMed]

    Supplementary Materials

    Figure 1—source data 1. qPCR Data.
    Figure 2—source data 1. Calcium imaging analysis summary, 2D TTX; WT, TKO.
    Figure 2—figure supplement 1—source data 1. Calcium imaging analysis summary, 5D TTX; WT, TKO.
    Figure 2—figure supplement 2—source data 1. Calcium imaging analysis summary, recovery.
    Figure 3—source data 1. mEPSC amplitude and frequency.
    Figure 4—source data 1. mIPSC amplitude and frequency.
    Figure 5—source data 1. Frequency-Current curves.
    Figure 6—source data 1. Calcium imaging analysis summary, 2D, 5D TTX; all genotypes.
    Figure 7—source data 1. Survival data by genotype.
    Figure 7—source data 2. Statistical analysis of survival data.
    MDAR checklist

    Data Availability Statement

    All data generated or analyzed during this study are included in the manuscript and supporting files, calcium imaging analysis code is available https://github.com/VH-Lab/vhlab-TwoPhoton-matlab (copy archived at Van Hooser, 2023). RNAseq data have been deposited to the BioSample database under accession numbers: SAMN31104764, SAMN31104765, SAMN31104766, SAMN31104767, SAMN31104768, SAMN31104769, SAMN31104770, SAMN31104771, SAMN31104772, SAMN31104773, SAMN31104774, and SAMN31104775.

    The following datasets were generated:

    Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104764

    Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104765

    Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104766

    Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104767

    Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104768

    Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104769

    Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104770

    Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104771

    Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104772

    Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104773

    Nelson S, Velakh V, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104774

    Nelson S, Velakh S, O'Toole S, Kirk R. 2022. A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex. NCBI BioSample. SAMN31104775


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES